Stanford University| Biochemistry| Stanford Genome Technology Center  

Home

Back

DHPLC Publication List (sorted by categories)

The DHPLC publication list is also available sorted by publication year

small bullet The Method small bullet Single Nucleotide Extension Sequencing and DHPLC
small bullet Sensitivity and Specificity small bullet DNA/RNA Purification
small bullet Mutational Analysis of Candidate Genes small bullet Mass Spectrometry and DHPLC
small bullet BRCA1 & BRCA2 small bullet Quantitation of Gene Expression by DHPLC
small bullet Tuberous Sclerosis small bullet Related Papers
small bullet Mapping and Positional Cloning small bullet Miscellaneous
small bullet Reverse Genetics small bullet Molecular Fingerprinting of Microorganisms
small bullet Human Evolution, Y-Chromosome small bullet DNA Methylation Analysis
   

The references below are hyper-linked to their abstract via PubMed or, whenever possible, directly to the journal. (Access to journals may require membership or subscription).

Please, forward new citations for inclusion in this list to oefner#genome.stanford.edu

 
Mutational Analysis of Candidate Genes
  1. Ophoff, R.A., Terwindt, G.M., Vergouwe, M.N., et al. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87(3):543-552.

  2. Wagner, T., Muhr, D., Hirtenlehner, K., Möslinger, R., Underhill, P., Scheiner, O., Kubista, E., Oefner, P.J. (1997) Founding BRCA1 and 2 mutations in Austrian HBOC families and individuals of the 5 continents. Am. J. Hum. Genet. 61 [Suppl.]:A86. (Abstract)

  3. Liu, W., Oefner, P., Qian, C., Odom, R., Francke, U. (1997) Denaturing HPLC identified novel FBN1 mutations, polymorphisms and sequence variants in Marfan syndrome patients. Am. J. Hum. Genet. 61 [Suppl.]:A223. (Abstract)

  4. Liu, W., James, C.D., Frederick, L., Aderete, B.E., Jenkins, R.B. (1997) PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res. 57(23):5254-5257.

  5. Ophoff, R.A., Terwindt, G.M., Vergouwe, M.N., Frants, R.R., Ferrari, M.D. (1997) Involvement of a Ca2+ channel gene in familial hemiplegic migraine and migraine with and without aura. Headache 37(8):479-485

  6. Yokomizo, A., Tindall, D.J., Drabkin, H., Gemmill, R., Franklin, W., Yang, P., Sugio, Y., Smith, D.I., Liu, W. (1998) PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 17(4):475-479.

  7. Liu, W., Smith, D.I., Rechtzigel, K.J.,Thibodeau, S.N. and James, C.D. (1998) Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucl. Acids Res. 26(6):1396-1400.

  8. Mai, M., Yokomizo, A., Qian, C., Yang, P., Tindall, D.J., Smith, D.I., and W. Liu. (1998) Activation of p73 silent allele in lung cancer. Cancer Res. 58(11):2347-2349.

  9. Liu, W.O., Oefner, P.J., Qian, C., Odom, R.S., Francke, U. (1998) Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders. Genet. Test. 1(4):237-242.

  10. Wagner, T.M.U., Moslinger, R.A., Muhr, D., et al. (1998) BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int. J. Cancer 77(3):354-360.

  11. Wagner, T., Hirtenlehner, K., Shen, P., Moeslinger, R., et al. (1998) High frequency of simple sequence variation in BRCA2: Analysis of 70 breast cancer families and 95 control individuals of world wide populations. Am. J. Hum. Genet. 63 [Suppl.]:A90.

  12. Huang, J.H., Oefner, P.J., Adi, V., Ratnam, K., Ruoss, S.J., Trako, E., Kao, P.N. (1998) Analyses of the NRAMP1 and IFN- g Receptor 1 genes in women with MAI pulmonary disease. Am. J. Respir. Crit. Care Med. 157(2):377-381.

  13. Martin, M.P., Dean, M., Smith, M.W., Winkler, C., Gerrard, B., Michael, N.L., Lee, B., Doms, R.W., Margolick, J., Buchbinder, S., Goedert, J.J., O'Brien, T.R., Hilgartner, M.W., Vlahov, D., O'Brien, S.J., Carrington, M. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911.

  14. Wagner, T., Stoppa-Lyonnet, D., Fleischmann, E., Muhr, D., Pagès, S., Sandberg, T., Caux, V., Moeslinger, R., Langbauer, G., Borg, A. and Oefner, P. (1999) Denaturing high performance liquid chromatography (DHPLC) detects reliably BRCA1 and BRCA2 mutations. Genomics 62:369-376.

  15. Wagner, T., Moeslinger, R., Fleischmann, E., Muhr, D., Hareter, M., Kofler, P., Austrian HBOC Group, Helbich, T., Zielinski, C., Oefner, P. (1999) BRCA1 Analysis by DHPLC in 272 Austrian Breast Cancer only and Breast and Ovarian Cancer Families. Am. J. Hum. Genet. 65 [Suppl.]:A328. (Abstract)

  16. Moeslinger, R., Wagner, T., Langbauer, G., Austrian HBOC Group, Auterith, A., Friedmann, A., Zielinski, C., Seifert, M., Oefner, P. (1999) Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Am. J. Hum. Genet. 65 [Suppl.]:A386. (Abstract)

  17. Oefner, P., Stoppa-Lyonnet, D., Fleischmann, E., Muhr, D., Pagès, S., Sandberg, T., Caux, V., Moeslinger, R., Langbauer, G., Borg, A., Wagner, T. (1999) Denaturing High Performance Liquid Chromatography (DHPLC) Detects BRCA1 and BRCA2 Mutations with High Sensitivity. Am. J. Hum. Genet. 65 [Suppl.]:A416 (Abstract)

  18. Yokomizo, A., Mai, M., Tindall, D.J., Cheng, L., Bostwick, D.G., Naito, S., Smith, D.I., Liu, W. (1999) Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 18(8):1629-1633.

  19. Yokomizo, A., Mai, M., Bostwick, D.G., Tindall, D.J., Qian, J., Cheng, L., Jenkins, R.B., Smith, D.I., Liu, W. (1999) Mutation and expression analysis of the p73 gene in prostate cancer. Prostate 39(2):94-100.

  20. Gross, E., Arnold, N., Goette, J., Schwarz-Boeger, U., Kiechle, M. (1999) A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum. Genet. 105(1-2):72-78.

  21. Arnold, N., Gross, E., Schwarz-Boeger, U., Pfisterer, J., Jonat, W., and Kiechle, M. (1999) A highly sensitive, fast and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum. Mutat. 14(4):333-339.

  22. Wagner, T.M.U., Hirtenlehner K., Shen, P., et. al. (1999) Global sequence diversity of BRCA2: Analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum. Mol. Gen. 8[3], 413-423.

  23. Whatley, S.D., Puy, H., Morgan, R.R., Robreau, A.M., Roberts, A.G., Nordmann, Y., Elder, G.H., Deybach, J.C. (1999) Variegate Porphyria in Western Europe: Identification of PPOX Gene Mutations in 104 Families, Extent of Allelic Heterogeneity, and Absence of Correlation between Phenotype and Type of Mutation. Am. J. Hum. Genet. 65(4):984-994.

  24. Cargill, M., Altshuler, D., Ireland, J., et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22(3):231-238.

  25. Sun, C., Skaletsky, H., Birren, B., Devon, K., Tang, Z., Silber, S., Oates, R., Page, D.C. (1999) An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y. Nature Genet. 23(4):429-432.

  26. Sevenet, N., Lellouch-Tubiana, A., Schofield, D., Hoang-Xuan, K., Gessler, M., Birnbaum, D., Jeanpierre, C., Jouvet, A., Delattre, O. (1999) Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum. Mol. Genet. 8(13):2359-2368.

  27. Wilgoss, A., Leigh, I.M., Barnes, M.R., Dopping-Hepenstal, P., Eady, R.A., Walter, J.M., Kennedy, C.T., Kelsell, D.P. (1999) Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis. J. Invest. Dermatol. 113(6):1119-1122.

  28. Bonner, R.M., Ballard, L.W. (1999) Considerations in adding mutation detection services to a sequencing core facility. J. Biomol. Tech. 10: 177-186.

  29. Dianzani, I., Landegren, U., Camaschella, C., Ponzone, A., Piazza, A., Cotton, R.G.H. (1999) Fifth International Mutation Detection Workshop, May 13-16, 1999, Vicoforte, Italy. Hum. Mutat. 14(6):451-453.

  30. Jacobsen, N.J., Lyons, I., Hoogendoorn, B., Burge, S., Kwok, P.Y., O'Donovan, M.C., Craddock, N., Owen, M.J. (1999) ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes. Hum Mol Genet Sep;8(9):1631-6.

  31. Jacobsen, N.J., Franks, E.K., Owen, M.J., and Craddock, N.J. (1999). Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder. Mol. Psychiatry 4, 274-279.

  32. Schrijver, I., Liu, W., Brenn, T., Furthmayr, H., and Francke, U. (1999). Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am. J. Hum. Genet. 65, 1007-1020.

  33. Schwartz DI, Lindor NM, Walsh-Vockley C, Roche PC, Mai M, Smith DI, Liu W, Couch FJ. (1999) p73 mutations are not detected in sporadic and hereditary breast cancer. Breast Cancer Res Treat 1999 Nov;58(1):25-9

  34. Okano, M., Bell, D.W., Haber, D.A., Li, E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257.

  35. Morita R, Miyazaki E, Shah PU, Castroviejo IP, Delgado-Escueta AV, Yamakawa K. (1999). Exclusion of the JRK/JH8 gene as a candidate for human childhood absence epilepsy mapped on 8q24. Epilepsy Res 37:151-158.

  36. Gross, E., Arnold, N., Pfeifer, K., Bandick, K., Kiechle, M. (2000) Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum. Mutat. 16(4):345-353.

  37. Wagner, T.M., Moslinger, R., Langbauer, G., Ahner, R., Fleischmann, E., Auterith, A., Friedmann, A., Helbich, T., Zielinski, C., Pittermann, E., Seifert, M., Oefner, P. (2000) Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Br. J. Cancer 82:1249-1253.

  38. Austin, J., Hoogendoorn, B., Buckland, P., Speight, G., Cardno, A., Bowen, T., Williams, N., Spurlock, G., Sanders, R., Jones, L., Murphy, K., McCarthy, G., McGuffin, P., Owen, M.J., O'Donovan, M.C. (2000) Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Mol. Psychiatry 5(2):208-12.

  39. Jogi, A., Abel, F., Sjoberg, R.M., Toftgard, R., Zaphiropoulos, P.G., Pahlman, S., Martinsson, T., Axelson, H. (2000) Patched 2, located in 1p32-34, is not mutated in high stage neuroblastoma tumors. Int. J. Oncol. 16(5):943-949.

  40. Graves, P.E., Kabesch, M., Halonen, M., Holberg, C.J., Baldini, M., Fritzsch, C., Weiland, S.K., Erickson, R.P., von Mutius, E., Martinez, F.D. (2000) A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. Allergy Clin. Immunol. 105(3):506-513.

  41. Eklund, A.C., Belchak, M.M., Lapidos, K., Raha-Chowdhury, R., Ober, C. (2000) Polymorphisms in the HLA-linked olfactory receptor genes in the Hutterites. Hum. Immunol. 6(7):711-717.

  42. Speight, G., Turic, D., Austin, J., Hoogendoorn, B., Cardno, A.G., Jones, L., Murphy, K.C., Sanders, R., McCarthy, G., Jones, I., McCandless, F., McGuffin, P., Craddock, N., Owen, M.J., Buckland, P., O'Donovan, M.C. (2000) Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Mol. Psychiatry 5(3):327-331.

  43. Nickerson, M.L., Weirich, G., Zbar, B., Schmidt, L.S. (2000) Signature-based analysis of MET proto-oncogene mutations using DHPLC. Hum. Mutat. 16(1):68-76.

  44. Deng, Z., Morse, J.H., Slager, S.L., Cuervo, N., Moore, K.J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S.G., Barst, R.J., Hodge, S.E., Knowles, J.A. (2000) Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor-II Gene. Am. J. Hum. Genet. 67(3):737-744.

  45. Jones, A.C., Sampson, J.R., Hoogendoorn, B., Cohen, D., Cheadle, J.P. (2000) Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Hum. Genet. 106(6):663-668.

  46. Santer, R., Rischewski, J., Block, G., Kinner, M., Wendel, U., Schaub, J., Schneppenheim, R. (2000) Molecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients. Hum. Mutat. 16(2):177.

  47. Giunta, C., Steinmann, B. (2000) Characterization of 11 new mutations in COL3A1 of individuals with Ehlers-Danlos syndrome type IV: preliminary comparison of RNase cleavage, EMC and DHPLC assays. Hum. Mutat. 16(2):176-177.

  48. Su, Z., Zhang, S., Hou, Y., Zhang, L., Liao, L., Xia, Q., Xiao, C., Meng, H., Yan, Y. (2000) A preliminary study of single nucleotide polymorphisms of lipoprotein lipase gene in coronary atherosclerotic heart disease [Article in Chinese]. Chung Hua Hsueh Chuan Hsueh Tsa Chih 17(3):157-160.

  49. Kaler, S.G., Devaney, J.M., Pettit, E.L., Kirshman, R., Marino, M.A. (2000) Novel method for molecular detection of the two common hereditary hemochromatosis mutations. Genet. Test 4(2):125-129.

  50. Weigell-Weber, M., Schinzel, A., Hergersberg, M. (2000) Mutational analysis of the connexin-26 gene in patients with autosomal recessive inherited hearing loss. Schweiz Med. Wochenschr. 130:1072-1077 (in German).

  51. van Den Bosch, B.J., de Coo, R.F., Scholte, H.R., Nijland, J.G., van Den Bogaard, R., de Visser, M., de Die-Smulders, C.E., Smeets, H.J. (2000) Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res. 28(20):E89.

  52. Lam, C.W., Sin, S.Y., Lau, E.T., Lam, Y.Y., Poon, P., Tong, S.F. (2000) Prenatal diagnosis of glycogen storage disease type 1b using denaturing high performance liquid chromatography. Prenat. Diagn. 20(9):765-768.

  53. Weigell-Weber, M., Schinzel, A., Hergersberg, M. (2000) Hereditary hearing loss due to mutations in the connexin-26 gene [Article in German). Schweiz Med. Wochenschr. 130(29-30):1072-1077.

  54. Wagner, T., Moeslinger, R., Muhr, D., Richards, D., Schreiber, M., Fleischmann, E., Austrian Hereditary Breast and Ovarian Cancer Group, Langbauer, G., Zielinski, C., Jin, L., Oefner, P. (2000) BRCA1 and BRCA2 analysis of 268 HBOC and HBC families by DHPLC. Am. J. Hum. Genet. 67 [Suppl. 2], 87.

  55. Shiri-Sverdlov, R., Oefner, P., Gershoni-Baruch, R., Green, L., Hofstra, R.M.W., Wagner, T., Friedman, E. (2000) Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Am. J. Hum. Genet. 67 [Suppl. 2], 88.

  56. Thorstenson, Y.R., Oefner, P.J., Goss, V., Davis, R.W., Gatti, R.A., Chu, G. (2000) Comprehensive mutational analysis of the ATM gene by denaturing HPLC. Am. J. Hum. Genet. 67 [Suppl. 2], 100.

  57. Moeslinger, R., Wagner, T., Langbauer, G., Austrian HBOC Group, Fleischmann, E., Autherith, A., Friedmann, A., Helbich, T., Oefner, P. (2000) Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Am. J. Hum. Genet. 67 [Suppl. 2], 202.

  58. Pawar, S., Ciocci, S., Markowitz, A., Jhanwar, S., Ellis, N. (2000) Denaturing high performance liquid chromatography (DHPLC) used in the detection of mutation in hMLH1 and hMSH2 genes. Am. J. Hum. Genet. 67 [Suppl. 2], 98.

  59. Bercovich, D., Lev-Lehman, E., Beaudet, A.L. (2000) Denaturing high performance liquid chromatography (DHPLC) used in the detection of mutations and polymorphisms in the UBE3A gene. Am. J. Hum. Genet. 67 [Suppl. 2], 246.

  60. Smeets, H., Van den Bosch, B., Nijland, J., Scholte, H., DeDie, C., Van den Bogaard, R., De Visser, M., De Coo, I. (2000) Mutation analysis of the entire mitochondrial DNA using denaturing high performance liquid chromatography (DHPLC). Am. J. Hum. Genet. 67 [Suppl. 2], 249.

  61. McAndrew, P.E., Devaney, J.M., Pettit, E.L., Schwartz, E.I., Stephan, D.A., Prior, T.W., Marino, M.A. (2000) Detection of mutations and heteroplasmy in the mitochondrial genome using denaturing high performance liquid chromatography. Am. J. Hum. Genet. 67 [Suppl. 2], 359.

  62. Lin, T., Suchy, S.F., Nussbaum, R.L. (2000) Lowe syndrome carrier testing by denaturing HPLC. Am. J. Hum. Genet. 67 [Suppl. 2], 402.

  63. Zhou, Z., Pace, R.G., Friedman, K.J., Zariwala, M., Noone, P.G., Knowles, M.R., Silverman, L.M. (2000) Rapid detection of rare mutations in multiple genetic disorders using DHPLC. Am. J. Hum. Genet. 67 [Suppl. 2], 245.

  64. Van Heerde, W.L., Kenis, H., Lux, P., Hamulyak, K., Wi, D., Lavergne, J.M.L.S., Reutelingsperger, C.P.M. (2000) Determination of the factor V Leiden (G1691A) and prothrombin (G20210A) mutations by using a DHPLC system. Am. J. Hum. Genet. 67 [Suppl. 2], 245.

  65. Harvey, J.F., Haynes, S.P., Eccles, D.M. (2000) DHPLC analysis of HPNCC: a rapid sensitive exon screen of hMLH1 and hMSH2. Am. J. Hum. Genet. 67 [Suppl. 2], 241.

  66. Bolino, A., Lonie, L., Zimmer, M., Boerkoel, C.F., Monaco, A.P., Lupski, J.R. (2000) DHPLC analysis of unrelated CMT patients in the Myotubularin related 2 gene, MTMR2, responsible for Charcot-Marie-Tooth disease type 4B. Am. J. Hum. Genet. 67 [Suppl.2], 372.

  67. Buyse, I.M., Fang, P., Hoon, K., Amir, R., Zoghbi, H., Roa, B.B. (2000) RETT syndrome diagnostic testing by DHPLC and sequence analysis of the MECP2 gene. Am. J. Hum. Genet. 67 [Suppl. 2], 393.

  68. Devaney, J.M., Hoffbuhr, K., Siranni, S.N., Naidu, S., Marino, M., Hoffman, E. (2000) DHPLC as a method for high throughput cost effective mutation screening: application to Rett syndrome. Am. J. Hum. Genet. 67 [Suppl. 2], 398.

  69. Takashima, H., Boerkoel, C.F., Lupski, J.R. (2000) The evaluation of mutation analysis using DHPLC in CMT patients with MPZ, PMP22, GJB1, EGR2 mutations. Am. J. Hum. Genet. 67 [Suppl. 2], 403.

  70. Van Der Loop, F.T., Heidet, L., Timmer, E.D., Van Den Bosch, B.J., Leinonen, A., Antignac, C., Jefferson, J.A., Maxwell, A.P., Monnens, L.A., Schroder, C.H., Smeets, H.J. (2000) Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int. 58(5):1870-1875.

  71. Benit, P., Kara-Mostefa, A., Berthelon, M., Sengmany, K., Munnich, A., Bonnefont, J.P. (2000) Mutation analysis of the hamartin gene using denaturing high performance liquid chromatography. Hum. Mutat. 16(5):417-421.

  72. Buyse, I.M., Fang, P., Hoon, K.T., Amir, R.E., Zoghbi, H.Y., Roa, B.B. (2000) Diagnostic Testing for Rett Syndrome by DHPLC and Direct Sequencing Analysis of the MECP2 Gene: Identification of Several Novel Mutations and Polymorphisms. Am. J. Hum. Genet. Dec;67(6):1428-36

  73. Kleymenova, E., Muga, S., Fischer, S., Walker, C.L. (2000) Application of high-performance liquid chromatography-based analysis of DNA fragments to molecular carcinogenesis. Mol. Carcinog. 29(2):51-58.

  74. Kiechle, M., Gross, E., Schwarz-Boeger, U., Pfisterer, J., Jonat, W., Gerber, W.D., Albacht, B., Fischer, B., Schlegelberger, B., Arnold, N. (2000). Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany. Hum. Mutat. 16(6):529-530.

  75. Escary, J.L., Cecillon, M., Maciazek, J., Lathrop, M., Tournier-Lasserve, E., Joutel, A. (2000) Evaluation of DHPLC analysis in mutational scanning of Notch3, a gene with a high G-C content. Hum. Mutat. 16(6):518-526.

  76. Shiri-Sverdlov, R., Oefner, P., Green, L., Baruch, R.G., Wagner, T., Kruglikova, A., Haitchick, S., Hofstra, R.M., Papa, M.Z., Mulder, I., Rizel, S., Bar Sade, R.B., Dagan, E., Abdeen, Z., Goldman, B., Friedman, E. (2000) Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Hum. Mutat. 16(6):491-501

  77. Pirulli, D., Giordano, M., Puzzer, D., Crovella, S., Rigato, I., Tiribelli, C., Momigliano-Richiardi, P., Amoroso, A. (2000) Rapid method for detection of extra (TA) in the promoter of the bilirubin-UDP-glucuronosyl transferase 1 gene associated with Gilbert syndrome. Clin Chem Jan;46(1):129-31

  78. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. (2000) New polymorphisms in the IL-10 promoter region. Genes Immun., 1(3):231-3

  79. Hecker KH, Asea A, Kobayashi K, Green S, Tang D, Calderwood SK. (2000) Mutation detection in the human HSP7OB' gene by denaturing high-performance liquid chromatography. Cell Stress Chaperones., 5(5):415-24

  80. Erlandson A, Stibler H, Kristiansson B, Wahlstrom J, Martinsson T. (2000) Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients. Genet Test., 4(3):293-7

  81. Orrico A, Lam C, Galli L, Dotti MT, Hayek G, Tong SF, Poon PM, Zappella M, Federico A, Sorrentino V. (2000) MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. Sep 22;481(3):285-8.

  82. Lam CW, Yeung WL, Ko CH, Poon PM, Tong SF, Chan KY, Lo IF, Chan LY, Hui J, Wong V, Pang CP, Lo YM, Fok TF. (2000) Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet. Dec;37(12):E41.

  83. Austin, J., Buckland, P., Cardno, A.G., Williams, N., Spurlock, G., Hoogendoorn, B., Zammit, S., Jones, G., Sanders, R., Jones, L., McCarthy, G., Jones, S., Bray, N.J., McGuffin, P., Owen, M.J., and O'Donovan, M.C. (2000). The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia. Mol. Psychiatry. Sep;5(5):552-557

  84. Austin, J., Hoogendoorn, B., Buckland, P., Speight, G., Cardno, A., Bowen, T., Williams, N., Spulock, G., Sanders, R., Jones, L., Murphy, K., McCarthy, G., McGuffin, P., Owen, M.J., and O´Donovan, M.C. (2000). Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Mol. Psychiatry 5, 208-212.

  85. Geurts, J.M.W., Janssen, R.G.J.H., van Greevenbroek, M.M.J., van der Kallen, C.J.H., Cantor, R.M., Bu, X., Aouizerat, B.E., Allayee, H., Rotter, J.I., and de Bruin, T.W.A. (2000). Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. Hum. Mol. Genet. 9, 2067-2074.

  86. Hauser, M.T., Horrigan, S.K., Salmikangas, P., Torian, U.M., Viles, K.D., Dancel, R., Tim, R.W., Taivainen, A., Bartoloni, L., Gilchrist, J.M., Stajich, J.M., Gaskell, P.C., Gilbert, J.R., Vance, J.M., Pericak-Vance, M.A., Carpen, O., Westbrook, C.A., and Speer, M.C. (2000). Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum. Mol. Genet. 9, 2141-2147.

  87. Liu, W., Mai, M., Yokomizo, A., Qian, C., Tindall, D.J., Smith, D.I., Thibodeau, S.N. (2000). Differential expression and allelotyping of the p73 gene in neuroblastoma. Int. J. Oncol. 16, 181-185.

  88. Rivera, A., White, K., Stohr, H., Steiner, K., Hemmrich, N., Grimm, T., Jurklies, B., Lorenz, B., Scholl, H.P.N., Apfelstedt-Sylla, E., and Weber, B.H.F. (2000). A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am. J. Hum. Genet. 67, 800-813.

  89. Seelan RS, Qian C, Yokomizo A, Bostwick DG, Smith DI, Liu W (2000) Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer. Oct;29(2):137-46

  90. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C, Christensen E, Schmidt SS, Roche PC, Smith DI, Thibodeau SN. (2000) Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet. Oct;26(2):146-7.

  91. Pickering-Brown S, Baker M, Yen SH, Liu WK, Hasegawa M, Cairns N, Lantos PL, Rossor M, Iwatsubo T, Davies Y, Allsop D, Furlong R, Owen F, Hardy J, Mann D, Hutton M. (2000) Pick's disease is associated with mutations in the tau gene. Ann Neurol. Dec;48(6):859-67.

  92. Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, Bowcock AM. (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet Apr;66(4):1192-1198.

  93. Bitner-Glindzicz M, Lindley KJ, Rutland P, Blaydon D, Smith VV, Milla PJ, Hussain K, Furth-Lavi J, Cosgrove KE, Shepherd RM, Barnes PD, O'Brien RE, Farndon PA, Sowden J, Liu XZ, Scanlan MJ, Malcolm S, Dunne MJ, Aynsley-Green A, Glaser B. (2000) A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet.Sep;26(1):56-60.

  94. Lowrey PL, Shimomura K, Antoch MP, Yamazaki S, Zemenides PD, Ralph MR, Menaker M, Takahashi JS. (2000). Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science 288, 483-491.

  95. Cotton, R.G.H., Bray, P.J. (2001) Using CCM and DHPLC to detect mutations in the glucocorticoid receptor in atherosclerosis: a comparison. J Biochem. Biophys. Meth. Jan;47(1-2):91-100

  96. Holinski-Feder, E., Mueller-Koch, Y., Friedl, W., Moeslein, G., Keller, G., Plaschke, J., Ballhausen, W., Gross, M., Baldwin-Jedele, K., Jungck, M., Mangold, E., Vogelsang, H., Schackert, H.-K., Lohsea, P., Murken, J., Meitinger, Th. (2001) DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem. Biophys. Meth. Jan;47(1-2):21-32

  97. Roberts, P.S., Jozwiak, S., Kwiatkowski, D.J., Dabora, S.L. (2001) Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene. J Biochem. Biophys. Meth. Jan;47(1-2):33-37

  98. Oldenburg, J., Ivaskevicius, V., Rost, S., Fregin, A., White, K., Holinski-Feder, E., Mueller, C.R., Weber, B.H.F. (2001) Evaluation of DHPLC in the analysis of hemophilia A. J Biochem. Biophys. Meth. Jan;47(1-2):39-51

  99. Rischewski, J., Schneppenheim, R. (2001) Screening strategies for a highly polymorphic gene: DHPLC analysis of the Fanconi anemia group A gene. J Biochem. Biophys. Meth. Jan;47(1-2):53-64

  100. Hall, A.G., Hamilton, P., Minto, L., Coulthard, S.A. (2001) The use of denaturing high-pressure liquid chromatography for the detection of mutations in thiopurine methyltransferase. J Biochem. Biophys. Meth. Jan;47(1-2):65-71

  101. Gross, E., Kiechle, M., Arnold, N. (2001) Mutation analysis of p53 ovarian tumors by DHPLC. J Biochem. Biophys. Meth. Jan;47(1-2):73-81

  102. Kleymenova, E., Walker, C.L. (2001) Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturing high-performance liquid chromatography (DHPLC). J Biochem. Biophys. Meth. Jan;47(1-2):83-90

  103. Lam CW, Hui KN, Poon PM, Luk NM, Yuen YP, Tong SF, Lai CK, Chan YW, Lo KK. (2001) Novel splicing mutation of the PPOX gene (IVS10+1G-->A) detected by denaturing high-performance liquid chromatography. Clin Chim Acta Mar; 305(1-2):197-200

  104. Cohn D, Mutch D, Elbendary A, Rader J, Herzog T, Goodfellow P. (2001) No evidence for BCL10 mutation in endometrial cancers with microsatellite instability. Hum Mutat.,17(2):117-21

  105. Passarino G, Shen P, Van Kirk JB, Lin AA, De Benedictis G, Cavalli Sforza LL, Oefner PJ, Underhill PA. (2001) The Werner syndrome gene and global sequence variation. Genomics., 71(1):118-22

  106. Schaeffeler E, Lang T, Zanger UM, Eichelbaum M, Schwab M. (2001) High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC. Clin Chem.;47(3):548-55.

  107. Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH, Risch N, Freimer NB. (2001) Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nature Genetics 27(4): 435-438.

  108. Benit P, Bonnefont JP, Kara Mostefa A, Francannet C, Munnich A, Ray PF. (2001) Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis. Prenat Diagn 21(4):279-283

  109. Zimmer R, Thomas P. (2001) Mutations in the Carcinoembryonic Antigen Gene in Colorectal Cancer Patients: Implications on Liver Metastasis. Cancer Res Apr 1;61(7):2822-2826

  110. Bolino, A., Leonie, L.J., Zimmer, M., Boerkoel, C.F., Takashima, H., Monaco, A.P., Lupski, J.R. (2001) Denaturing high-performance liquid chromatography of the myotubularin-related 2 gene (MTMR2) in unrelated patients with Charcot-Marie-Tooth disease suggests a low frequency of mutation in inherited neuropathy. Neurogenetics Mar;3(2):107-9

  111. Berggren, M.M., Powis, G. (2001) Alternative splicing is associated with decreased expression of the redox proto-oncogene thioredoxin-1 in human cancers. Arch Biochem Biophys May 1;389(1):144-9

  112. Benit P, Chretien D, Kadhom N, de Lonlay-Debeney P, Cormier-Daire V, Cabral A, Peudenier S, Rustin P, Munnich A, Rotig A. (2001) Large-Scale Deletion and Point Mutations of the Nuclear NDUFV1 and NDUFS1 Genes in Mitochondrial Complex I Deficiency. Am J Hum Genet. Jun;68(6):1344-1352

  113. Zimmer R, Thomas P. (2001) Mutations in the carcinoembryonic antigen gene in colorectal cancer patients: implications on liver metastasis. Cancer Res. Apr 1;61(7):2822-6.

  114. Le Marechal C, Audrezet MP, Quere I, Raguenes O, Langonne S, Ferec C. (2001) Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum Genet. Apr;108(4):290-8

  115. Christiansen L, Bygum A, Kaehne M, Jensen A, Horder M, Petersen NE. (2001) Mutation screening of the entire coding region of the protoporphyrinogen oxidase gene using denaturing gradient gel electrophoresis and denaturing hplc. Clin Chem. Jun;47(6):1115-7

  116. Pitarque M, von Richter O, Oke B, Berkkan H, Oscarson M, Ingelman-Sundberg M. (2001) Identification of a single nucleotide polymorphism in the tata box of the cyp2a6 gene: impairment of its promoter activity. Biochem Biophys Res Commun. Jun 8;284(2):455-60

  117. Bowen T, Williams N, Norton N, Spurlock G, Wittekindt OH, Morris-Rosendahl DJ, Williams H, Brzustowicz L, Hoogendoorn B, Zammit S, Jones G, Sanders RD, Jones LA, McCarthy G, Jones S, Bassett A, Cardno AG, Owen MJ, O'Donovan MC. (2001) Mutation screening of the KCNN3 gene reveals a rare frameshift mutation. Mol Psychiatry. May;6(3):259-60

  118. Taliani MR, Roberts SC, Dukek BA, Pruthi RK, Nichols WL, Heit JA. (2001) Sensitivity and specificity of denaturing high-pressure liquid chromatography for unknown protein C gene mutations. Genet Test. Spring;5(1):39-44.

  119. Hoffbuhr K, Devaney JM, LaFleur B, Sirianni N, Scacheri C, Giron J, Schuette J, Innis J, Marino M, Philippart M, Narayanan V, Umansky R, Kronn D, Hoffman EP, Naidu S. (2001) MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology. Jun 12;56(11):1486-95.

  120. Lam CW, Poon PM, Tong SF, Ko CH. (2001) Two novel CLN2 gene mutations in a Chinese patient with classical late-infantile neuronal ceroid lipofuscinosis. Am J Med Genet. Mar 1;99(2):161-3

  121. Lam CW, Poon PM, Tong SF, Lo AW, Lai CK, Choi KL, Tiu SC, Chan YW, Shek CC. (2001) Novel mutation and polymorphisms of the HMBS gene detected by denaturing HPLC. Clin Chem. 2001 Feb;47(2):343-6.

  122. Wolford JK, Hanson RL, Bogardus C, Prochazka M. (2001) Analysis of the lamin A/C gene as a candidate for type II diabetes susceptibility in Pima Indians. Diabetologia. Jun;44(6):779-82.

  123. Boutin P, Vasseur F, Samson C, Wahl C, Froguel P. (2001) Routine mutation screening of HNF-1alpha and GCK genes in MODY diagnosis: how effective are the techniques of DHPLC and direct sequencing used in combination? Diabetologia.Jun;44(6):775-8.

  124. Lin D, Goldstein JA, Mhatre AN, Lustig LR, Pfister M, Lalwani AK. (2001) Assessment of denaturing high-performance liquid chromatography (DHPLC) in screening for mutations in connexin 26 (GJB2). Hum Mutat;18(1):42-51.

  125. Girard M, Couvert P, Carrie A, Tardieu M, Chelly J, Beldjord C, Bienvenu T. (2001). Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet 9(3):231-236.

  126. Niu T, Seielstad M, Zeng X, Apffel A, Li G, Hahnenberger K, Xu X. (2001) Detection of novel ALAD gene polymorphisms using denaturing high-performance liquid chromatography. Hum Biol. Jun;73(3):429-42.

  127. Xiao W, Stern D, Jain M, Huber CG, Oefner PJ. (2001) Multiplex capillary denaturing high-performance liquid chromatography with laser-induced fluorescence detection. Biotechniques. Jun;30(6):1332-8

  128. Boerkoel, C.F., Takashima, H., Stankiewicz, P., Garcia, C.A., Leber, S.M., Rhee-Morris, L., and Lupski, J.R. (2001). Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am. J. Hum. Genet. 68, 325-333.

  129. Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., and De Jonghe, P. (2001). De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68, 1327-1332.

  130. Devaney, J.M., Pettit, E.L., Kaler, S.G., Vallone, P.M., Butler, J.M., and Marino, M.A. (2001). Genotyping of two mutations in the HFE gene using single-base extension and high-performance liquid chromatography. Anal. Chem. 73, 620-624.

  131. Jacobsen, N.J., Elvidge, G., Franks, E.K., O´Donovan, M.C., Craddock, N., and Owen, M.J. (2001). CUX2, a potential regulator of NCAM expression: Genomic characterization and analysis as a positional candidate susceptibility gene for bipolar disorder. Am. J. Med. Genet. 105, 295-300.

  132. Jacobsen, N.J.O., Franks, E.K.E., Elvidge, G., Jones, I., McCandless, F., O´Donovan, M.C., Owen, M.J., and Craddock, N. (2001). Exclusion of the Darier´s disease gene, ATP2A2, as a common susceptibility gene for bipolar disorder. Mol. Psychiatry 6, 92-97.

  133. Klein, B., Weirich, G., and Brauch, H. (2001) DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum. Genet. 108, 376-384.

  134. Liang, Q., Davis, P.A., Thompson, B.H., and Simpson, J.T. (2001). High-performance liquid chromatography multiplex detection of two single nucleotide mutations associated with hereditary hemochromatosis. J. Chromatogr. B Biomed. Sci. Appl. 754, 265-270.

  135. Lipkin, S.M., Wang, V., Stoler, D.L., Anderson, G.R., Kirsch, I., Hadley, D., Lynch, H.T., and Collins, F.S. (2001). Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Hum. Mutat. 17, 389-396.

  136. Nicolao P, Carella M, Giometto B, Tavolato B, Cattin R, Giovannucci-Uzielli ML, Vacca M, Regione FD, Piva S, Bortoluzzi S, Gasparini P. (2001) DHPLC analysis of the MECP2 gene in Italian Rett patients. Hum Mutat. Aug;18(2):132-40.

  137. Sauer CG, White K, Stohr H, Grimm T, Hutchinson A, Bernstein PS, Lewis RA, Simonelli F, Pauleikhoff D, Allikmets R, Weber BH. Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration. Br J Ophthalmol. 2001 Aug;85(8):969-75.

  138. Cox D, Boillot C, Canzian F. (2001) Data mining: Efficiency of using sequence databases for polymorphism discovery. Hum Mutat. Feb;17(2):141-50

  139. Ribas G, Neville MJ, Campbell RD. (2001) Single-nucleotide polymorphism detection by denaturing high-performance liquid chromatography and direct sequencing in genes in the MHC class III region encoding novel cell surface molecules. Immunogenetics. Jul;53(5):369-381.

  140. Marsh DJ, Theodosopoulos G, Howell V, Richardson AL, Benn DE, Proos AL, Eng C, Robinson BG. (2001) Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia. May-Jun;3(3):236-44.

  141. Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR, Concannon P. (2001) Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer. Aug 1;92(3):479-87.

  142. Le Gac G, Mura C, Ferec C. (2001) Complete scanning of the hereditary hemochromatosis gene (hfe) by use of denaturing HPLC. Clin Chem. Sep;47(9):1633-40.

  143. Matsubara A, Wasson JC, Donelan SS, Welling CM, Glaser B, Permutt MA. (2001) Isolation and characterization of the human AKT1 gene, identification of 13 single nucleotide polymorphisms (SNPs), and their lack of association with Type II diabetes. Diabetologia. Jul;44(7):910-3.

  144. Donn RP, Shelley E, Ollier WE, Thomson W. (2001) A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. Aug;44(8):1782-5.

  145. Thorstenson, Y.R., Shen, P., Tusher, V.G., Davis, R.W., Chu, G., Oefner, P.J. (2001) Global analysis of ATM polymorphism reveals significant functional constraint. Am.J.Hum.Genet. 69, 396-412.

  146. Takashima H, Boerkoel CF, Lupski JR. (2001) Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy. Genet Med. Sep-Oct;3(5):335-342.

  147. Lindor NM, Dechet CB, Greene MH, Jenkins RB, Zincke MT, Weaver AL, Wilson M, Zincke H, Liu W. (2001) Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population. Genet Test. Summer;5(2):101-6.

  148. Mizoguchi M, Tamura T, Yamaki A, Higashihara E, Shimizu Y. (2001) Mutations of the PKD1 gene among Japanese autosomal dominant polycystic kidney disease patients, including one heterozygous mutation identified in members of the same family. J Hum Genet;46(9):511-517

  149. Drury KC, Liu MC, Lilleberg S, Kipersztok S, Williams RS. (2001) Results on single cell PCR for Huntington's gene and WAVE product analysis for preimplantation genetic diagnosis. Mol Cell Endocrinol. Oct 22;183 Suppl 1:S1-4

  150. Thorstenson, Y.R., Roxas, A., Kroiss, R., Wagner, T., Oefner, P.J. (2001) Germline carriers of ATM mutations are prevalent among Austrian hereditary breast and ovarian cancer (HBOC) patients. Am. J. Hum. Genet. 69 [Suppl.], 205

  151. Orlow I, Roy P, Barz A, Canchola R, Song Y, Berwick M. (2001) Validation of Denaturing High Performance Liquid Chromatography as a Rapid Detection Method for the Identification of Human INK4A Gene Mutations. J Mol Diagn. Nov;3(4):158-163.

  152. Menegatti E, Ferrone M, Gallone S, Mameli M, Grosso E, Migone N. (2001) Molecular genetic analysis of von Hippel-Lindau disease by denaturing high-performance liquid chromatography. Contrib Nephrol.;(136):306-11.

  153. Bernstein PS, Tammur J, Singh N, Hutchinson A, Dixon M, Pappas CM, Zabriskie NA, Zhang K, Petrukhin K, Leppert M, Allikmets R. (2001) Diverse Macular Dystrophy Phenotype Caused by a Novel Complex Mutation in the ELOVL4 Gene. Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3331-3336.

  154. Bennett RR, Dunnen J, O'Brien KF, Darras BT, Kunkel LM. (2001) Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet. ;2(1):17.

  155. Pirulli D, Giordano M, Lessi M, Spano A, Puzzer D, Zezlina S, Boniotto M, Crovella S, Florian F, Marangella M, Momigliano-Richiardi P, Savoldi S, Amoroso A. (2001) Detection of AGXT bgene mutations by denaturing high-performance liquid chromatography for diagnosis of hyperoxaluria type 1. Clin Exp Med. Jun;1(2):99-104.

  156. Wolford JK, Thameem F, Bogardus C, Prochazka M. (2001) Polymorphism screening of the insulin receptor-related receptor gene (INSRR) on 1q in Pima Indians. Mol Cell Probes 15:223-227.

  157. Ishii T, Sato S, Kosaki K, Sasaki G, Muroya K, Ogata T, Matsuo N. (2001) Micropenis and the AR Gene: Mutation and CAG Repeat-Length Analysis. J Clin Endocrinol Metab. 86(11):5372-5378.

  158. Han SS, Cooper DN, Upadhyaya MN. (2001) Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene. Hum Genet. Nov;109(5):487-497.

  159. Le Marechal C, Chen JM, Quere I.I, Raguenes O, Ferec C, Auroux J. (2001) Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography. BMC Genet.;2(1):19.

  160. Devon RS, Anderson S, Teague PW, Burgess P, Kipari TM, Semple CA, Millar JK, Muir WJ, Murray V, Pelosi AJ, Blackwood DH, Porteous DJ. (2001) Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet.Jun;11(2):71-8.

  161. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, Figlewicz DA, Kwiatkowski T, Hosler BA, Sagie T, Skaug J, Nasir J, Brown RH Jr, Scherer SW, Rouleau GA, Hayden MR, Ikeda JE. (2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet.Oct;29(2):166-73.

  162. Keller G, Hartmann A, Mueller J, Hofler H. (2001) Denaturing High Pressure Liquid Chromatography (DHPLC) for the Analysis of Somatic p53 Mutations. Lab Invest.Dec;81(12):1735-1737.

  163. zur Stadt U, Rischewski J, Schneppenheim R, Kabisch H. (2001). Denaturing HPLC for identification of clonal T-cell receptor gamma rearrangements in newly diagnosed acute lymphoblastic leukemia. Clin Chem 47:2003-2011.

  164. Atencio DP, Iannuzzi CM, Green S, Stock RG, Bernstein JL, Rosenstein BS. (2001) Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography. Environ Mol Mutagen. 2001;38(2-3):200-208.

  165. Pallares-Ruiz N, Blanchet P, Mondain M, Low-Hong S, Demaille J, Claustres M, Roux AF. (2001) Evaluation of dHPLC for CX26 mutation screening in patients from southern France with sensorineural deafness. Genet Test. Winter;5(4):339-43.

  166. Wu G, Wu W, Hegde M, Fawkner M, Chong B, Love D, Su LK, Lynch P, Snow K, Richards CS. (2001) Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography. Genet Test. Winter;5(4):281-90.

  167. Tomka M, Sedlakova O, Reinerova M, Veselovska Z, Stevurkova V, Bartosova Z, Zajac V. (2001). Mutation screening of the BRCA1 gene in Slovak patients. Neoplasma 48:451-455.

  168. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A. (2001). Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10, 189-194.

  169. Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H. (2001). Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10, 1215-1220.

  170. Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM. (2001). BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160.

  171. Varon R, Reis A, Henze G, von Einsiedel HG, Sperling K, Seeger K. (2001). Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res. 61, 3570-3572.

  172. Vithana EN, Abu-Safieh L, Allen MJ, Carey A, Papaioannou M, Chakarova C, Al-Maghtheh M, Ebenezer ND, Willis C, Moore AT, Bird AC, Hunt DM, Bhattacharya SS. (2001). A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol. Cell. 8, 375-381.

  173. Lev-Lehman E, Bercovich D, Xu W, Stockton DW, Beaudet AL. (2001). Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4. J. Hum. Genet. 46, 362-366.

  174. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML, Allikmets R, Zack DJ, Kakuk LE, Lagali PS, Wong PW, MacDonald IM, Sieving PA, Figueroa DJ, Austin CP, Gould RJ, Ayyagari R, Petrukhin K. (2001). A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat. Genet. 27, 89-93.

  175. Ayyagari R, Zhang K, Hutchinson A, Yu Z, Swaroop A, Kakuk LE, Seddon JM, Bernstein PS, Lewis RA, Tammur J, Yang Z, Li Y, Zhang H, Yashar BM, Liu J, Petrukhin K, Sieving PA, Allikmets R. (2001) Evaluation of the ELOVL4 gene in patients with age-related macular degeneration. Ophthalmic Genet. Dec;22(4):233-9.

  176. Thameem F, Wolford JK, Bogardus C, Prochazka M. (2001). Analysis of PBX1 as a candidate gene for type 2 diabetes mellitus in Pima Indians. Biochim. Biophys. Acta. 1518, 215-220.

  177. Sugimoto Y, Morita R, Amano K, Shah PU, Pascual-Castroviejo I, Khan S, Delgado-Escueta AV, Yamakawa K. (2001). T-STAR gene: fine mapping in the candidate region for childhood absence epilepsy on 8q24 and mutational analysis in patients. Epilepsy Res. 46, 139-144.

  178. Maeyama K, Kosaki R, Yoshihashi H, Casey B, Kosaki K. (2001). Mutation analysis of left-right axis determining genes in NOD and ICR, strains susceptible to maternal diabetes. Teratology 63, 119-126.

  179. Elanko N, Sibbring JS, Metcalfe KA, Clayton-Smith J, Donnai D, Temple IK, Wall SA, Wilkie AO. (2001). A survey of TWIST for mutations in craniosynostosis reveals a variable length polyglycine tract in asymptomatic individuals. Hum. Mutat. 18, 535-541.

  180. Salahshor, S., Haixin, L., Huo, H., Kristensen, V.N., Loman, N., Sjoberg-Margolin, S., Borg, A., Borresen-Dale, A.L., Vorechovsky, I., Lindblom, A. (2001). Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res. 3, 199-207.

  181. Nakano, M., Yamada, K., Fain, J., Sener, E.C., Selleck, C.J., Awad, A.H., Zwaan, J., Mullaney, P.B., Bosley, T.M., Engle, E.C. (2001). Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2. Nat. Genet. 29, 315-320.

  182. Hudson BI, Stickland MH, Futers TS, Grant PJ. (2001). Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50, 1505-1511.

  183. Hull J, Ackerman H, Isles K, Usen S, Pinder M, Thomson A, Kwiatkowski D. (2001). Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am. J. Hum. Genet. 69, 413-419.

  184. Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, Rondon H, Lantigua RA, Medrano M, Torres M, Arawaka S, Rogaeva E, Song Y-Q, Sato C, Kawarai T, Fafel KC, Boss MA, Seltzer WK, Stern Y, George-Hyslop PS, Tycko B, Mayeux R. (2001). A founder mutation in Presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA 286, 2257-2263.

  185. Quintanilla-Martinez L, Kremer M, Keller G, Nathrath M, Gamboa-Dominguez A, Meneses A, Luna-Contreras L, Cabras A, Hoefler H, Mohar A, Fend F. (2001). P53 mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.Am J Pathol 159, 2095-2105. 

  186. Heath KE, Campos-Barros A, Toren A, Rozenfield-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF, Greinacher A, Epstein CJ, Glucksman MJ, Martignetti JA. ( 2001). Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-Like syndromes Am. J. Hum. Genet. 69, 1033-1045.

  187. Ranade K, Wu KD, Hwu CM, Ting CT, Pei D, Pesich R, Hebert J, Chen YD, Pratt R, Olshen R, Masaki K, Risch N, Cox DR, Botstein D. (2001). Genetic variation in the human urea transporter-2 is associated with variation in blood pressure. Hum. Mol. Genet. 10, 2157-2164.

  188. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K. (2001). Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103, 485-490.

  189. Muroya K, Sasagawa I, Suzuki Y, Nakada T, Ishii T, Ogata T. (2001). Hypospadias and the androgen receptor gene: mutation screening and CAG repeat length analysis. Mol. Hum. Reprod. 7, 409-413.

  190. Eccles D, Harvey J, Bateman A, Ross F. (2001). A novel 3' mutation in the APC gene in a family presenting with a desmoid tumour. J. Med. Genet. 38, 861-863.

  191. Blair E, Price SJ, Baty CJ, Ostman-Smith I, Watkins H. (2001). Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy. J. Med. Genet. 38, 385-423.

  192. Kelberman D, Tyson J, Chandler DC, McInerney AM, Slee J, Albert D, Aymat A, Botma M, Calvert M, Goldblatt J, Haan EA, Laing NG, Lim J, Malcolm S, Singer SL, Winter RM, Bitner-Glindzicz M. (2001). Hemifacial microsomia: progress in understanding the genetic basis of a complex malformation syndrome. Hum. Genet. 109, 638-645.

  193. van Heel DA, Carey AH, Jewell DP. (2001). Identification of novel polymorphisms in the beta7 integrin gene: family-based association studies in inflammatory bowel disease. Genes Immun. 2, 455-460

  194. Rickard S, Kelsell DP, Sirimana T, Rajput K, MacArdle B, Bitner-Glindzicz M. (2001). Recurrent mutations in the deafness gene GJB2 (connexin 26) in British Asian families. J Med Genet 38:530-533.

  195. Amini-Nekoo A, Futers TS, Moia M, Mannucci PM, Grant PJ, Ariens RA. (2001). Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br J Haematol 113, 537-543.

  196. Malandrini A, Mari F, Palmeri S, Gambelli S, Berti G, Bruttini M, Bardelli AM, Williamson K, van Heyningen V, Renieri A. (2001). PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation. Clin Genet 60, 151-154.

  197. Bacon AL, Farrington SM, Dunlop MG. (2001). Mutation frequency in coding and non-coding repeat sequences in mismatch repair deficient cells derived from normal human tissue. Oncogene 20, 7464-7471.

  198. Gerber S, Perrault I, Hanein S, Barbet F, Ducroq D, Ghazi I, Martin-Coignard D, Leowski C, Homfray T, Dufier JL, Munnich A, Kaplan J, Rozet JM. (2001). Complete exon-intron structure of the RPGR-interacting protein (RPGRIP1) gene allows the identification of mutations underlying Leber congenital amaurosis. Eur. J. Hum. Genet. 9, 561-571.

  199. Devon RS, Anderson S, Teague PW, Muir WJ, Murray V, Pelosi AJ, Blackwood DH, Porteous DJ. (2001). The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol. Psychiatry 6, 311-314.

  200. Erlandson A, Bjursell C, Stibler H, Kristiansson B, Wahlstrom J, Martinsson T. (2001). Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations. Hum. Genet. 108, 359-367.

  201. Lin WH, Chiu KC, Chang HM, Lee KC, Tai TY, Chuang LM. (2001). Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum. Mol. Genet. 10, 1753-1760.

  202. Cruts M, Dermaut B, Rademakers R, Roks G, Van den Broeck M, Munteanu G, van Duijn CM, Van Broeckhoven C. (2001). Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. Neurosci. Lett. 313, 105-107.

  203. Moller P, Borg A, Heimdal K, Apold J, Vallon-Christersson J, Hovig E, Maehle L; The Norwegian Inherited Breast Cancer Group.; The Norwegian Inherited Ovarian Cancer Group. (2001). The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series. Eur. J. Cancer 37, 1027-1032.

  204. Szeto CY, Tang NL, Lee DT, Stadlin A. (2001). Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport 12, 1103-1106.

  205. Cobb CJ, Scott G, Swingler RJ, Wilson S, Ellis J, MacEwen CJ, McLean WH. (2002) Rapid mutation detection by the Transgenomic wave analyser DHPLC identifies MYOC mutations in patients with ocular hypertension and/or open angle glaucoma. Br J Ophthalmol. Feb;86(2):191-195.

  206. Lam CW, Li CK, Lai CK, Tong SF, Chan KY, Ng GS, Yuen YP, Cheng AW, Chan YW. (2002) DNA-Based Diagnosis of Isolated Sulfite Oxidase Deficiency by Denaturing High-Performance Liquid Chromatography. Mol Genet Metab. Jan;75(1):91-95.

  207. Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS. (2002) ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys, Mar 1;52(3):606-613

  208. Colosimo A, Guida V, De Luca A, Cappabianca MP, Bianco I, Palka G, Dallapiccola B. (2002) Reliability of DHPLC in mutational screening of [beta]-globin (HBB) alleles. Hum Mutat Mar;19(3):287-295

  209. Bunn CF, Lintott CJ, Scott RS, George PM. (2002) Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort. Hum Mutat Mar;19(3):311

  210. Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott RJ, Lubinski J. (2002) Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods. Mar 4;51(1):89-100.

  211. Yamamoto N, Nakayama J, Yamakawa-Kobayashi K, Hamaguchi H, Miyazaki R, Arinami T. (2002). Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum Mutat 19:251-257.

  212. Yamamoto N, Nakayama J, Yamakawa-Kobayashi K, Hamaguchi H, Miyazaki R, Arinami T. (2002). Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum Mutat 19:251-257.

  213. Ravnik-Glavac M, Atkinson A, Glavac D, Dean M. (2002) DHPLC screening of cystic fibrosis gene mutations. Hum Mutat. Apr;19(4):374-83.

  214. Matyas G, De Paepe A, Halliday D, Boileau C, Pals G, Steinmann B. (2002) Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: Identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene. Hum Mutat. Apr;19(4):443-56.

  215. Shi J, Hui L, Xu Y, Wang F, Huang W, Hu G. (2002) Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat. Apr;19(4):459-60.

  216. Webster MT, Wells RS, Clegg JB. (2002) Analysis of variation in the human beta-globin gene cluster using a novel DHPLC technique. Mutat Res. Apr 25;501(1-2):99-103.

  217. D'Alfonso S, Mellai M, Giordano M, Pastore A, Malferrari G, Naldi P, Repice A, Liguori M, Cannoni S, Milanese C, Caputo D, Savettieri G, Momigliano-Richiardi P. (2002) Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene and study of their association with multiple sclerosis. J Neuroimmunol. May;126(1-2):196-204.

  218. Rossetti S, Chauveau D, Walker D, Saggar-Malik A, Winearls CG, Torres VE, Harris PC. (2002) A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int. May;61(5):1588-99.

  219. Deng L, Zhao XR, Pan KF, Wang Y, Deng XY, Lu YY, Cao Y. (2002) Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). Jan;34(1):16-20.

  220. Pissard S, Huynh LT, Martin J, Goossens M.(2002). HFE genotyping by amplification refractory mutation system-denaturing HPLC. Clin Chem 48:769-772.

  221. Miraglia Del Giudice E, Cirillo G, Nigro V, Santoro N, D'Urso L, Raimondo P, Cozzolino D, Scafato D, Perrone L. (2002) Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes Relat Metab Disord 26: 647-651.

  222. Flex E, De Luca A, D'Apice MR, Buccino A, Dallapiccola B, Novelli G. (2002) Rapid scanning of myotubularin (MTM1) gene by denaturing high-performance liquid chromatography (DHPLC). Neuromuscul Disord 12:501-505.

  223. Liu MR, Pan KF, Li ZF, Wang Y, Deng DJ, Zhang L, Lu YY. (2002). Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography. World J Gastroenterol 8:426-430.

  224. Desai PP, Bunker CH, Ukoli FA, Kamboh MI. (2002). Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. Atherosclerosis 163(2):329-338.

  225. Ezzeldin H, Okamoto Y, Johnson MR, Diasio RB. (2002) A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency. Anal Biochem. 2002 Jul 1;306(1):63-73.

  226. Antonarakis ES, Sampson JR, Cheadle JP. (2002) Temperature modulation of DHPLC analysis for detection of coexisting constitutional and mosaic sequence variants in TSC2. J Biochem Biophys Methods. 2002 Apr 18;51(2):161-4.

  227. Schrijver I, Liu W, Odom R, Brenn T, Oefner P, Furthmayr H, Francke U. (2002) Premature Termination Mutations in FBN1: Distinct Effects on Differential Allelic Expression and on Protein and Clinical Phenotypes. Am J Hum Genet. 2002 Aug 71(2):223-237.

  228. Rugg EL, Common JE, Wilgoss A, Stevens HP, Buchan J, Leigh IM, Kelsell DP. (2002) Diagnosis and confirmation of epidermolytic palmoplantar keratoderma by the identification of mutations in keratin 9 using denaturing high-performance liquid chromatography. Br J Dermatol. Jun;146(6):952-957.

  229. Baumer A. (2002) Analysis of the methylation status of imprinted genes based on methylation-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography. Methods. Jun;27(2):139-43.

  230. Vatta M, Dumaine R, Antzelevitch C, Brugada R, Li H, Bowles NE, Nademanee K, Brugada J, Brugada P, Towbin JA. (2002). Novel mutations in domain I of SCN5A cause Brugada syndrome. Mol. Genet. Metab. 75, 317-324.

  231. Li H, Yamagata T, Mori M, Momoi MY. (2002). Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1. J. Hum. Genet. 47, 262-265.

  232. Leonard DG, Travis LB, Addya K, Dores GM, Holowaty EJ, Bergfeldt K, Malkin D, Kohler BA, Lynch CF, Wiklund T, Stovall M, Hall P, Pukkala E, Slater DJ, Felix CA. (2002). p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer. Clin. Cancer Res. 8, 973-985.

  233. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC. (2002). KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size. Am J Pathol 160, 1567-1572.

  234. Todd RD, Lobos EA. (2002). Mutation screening of the dopamine D2 receptor gene in attention-deficit hyperactivity disorder subtypes: Preliminary report of a research strategy. Am. J. Hum. Genet. 114, 34-41.

  235. Jensen MA, Charlesworth B, Kreitman M. (2002). Patterns of Genetic Variation at a Chromosome 4 Locus of Drosophila melanogaster and D. simulans. Genetics 160, 493-507.

  236. Newbury DF, Bonora E, Lamb JA, Fisher SE, Lai CS, Baird G, Jannoun L, Slonims V, Stott CM, Merricks MJ, Bolton PF, Bailey AJ, Monaco AP. (2002). FOXP2 Is Not a Major Susceptibility Gene for Autism or Specific Language Impairment. Am. J. Hum. Genet. 70, 1318-1327.

  237. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, Rudnik-Schoneborn S, Mrug M, Sweeney W, Avner ED, Zerres K, Guay-Woodford LM, Somlo S, Germino GG. (2002). PKHD1, the Polycystic Kidney and Hepatic Disease 1 Gene, Encodes a Novel Large Protein Containing Multiple Immunoglobulin-Like Plexin-Transcription-Factor Domains and Parallel Beta-Helix 1 Repeats. Am. J. Hum. Genet. 70, 1305-1317.

  238. Yang P, Yokomizo A, Tazelaar HD, Marks RS, Lesnick TG, Miller DL, Sloan JA, Edell ES, Meyer RL, Jett J, Liu W. (2002). Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer 35, 221-229.

  239. Richter-Unruh A, Martens JW, Verhoef-Post M, Wessels HT, Kors WA, Sinnecker GH, Boehmer A, Drop SL, Toledo SP, Brunner HG, Themmen AP. (2002). Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin. Endocrinol. 56, 103-112.

  240. Chakarova CF, Hims MM, Bolz H, Abu-Safieh L, Patel RJ, Papaioannou MG, Inglehearn CF, Keen TJ, Willis C, Moore AT, Rosenberg T, Webster AR, Bird AC, Gal A, Hunt D, Vithana EN, Bhattacharya SS. (2002). Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa. Hum. Mol. Genet. 11, 87-92.

  241. Donaldson IJ, Shefta J, Lawson CA, Bushnell JR, Morgan AW, Isaacs JD, Carpenter D, Shaw MA, Rooth I, Quinnell RJ, Zumla AM, Ollier WR, Chintu CZ, Muyinda GP, Hill AS, Boylston AW. (2002). Unique TCR beta-subunit variable gene haplotypes in Africans. Immunogenetics 53, 884-893.

  242. Taniguchi K, Yang P, Jett J, Bass E, Meyer R, Wang Y, Deschamps C, Liu W. (2002). Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. Clin. Cancer Res. 8, 1115-1120.

  243. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. (2002). Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. 99, 1978-1983.

  244. Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, Tomkins S, Verloes A, Twigg SR, Rannan-Eliya S, McDonald-McGinn DM, Zackai EH, Wall SA, Muenke M, Wilkie AO. (2002). Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am. J. Hum. Genet. 70, 472-486. 

  245. Fujita H, Kosaki R, Yoshihashi H, Ogata T, Tomita M, Hasegawa T, Takahashi T, Matsuo N, Kosaki K. (2002). Characterization of the aryl hydrocarbon receptor repressor gene and association of its Pro185Ala polymorphism with micropenis. Teratology 65, 10-18.

  246. Lei H, Sjoberg-Margolin S, Salahshor S, Werelius B, Jandakova E, Hemminki K, Lindblom A, Vorechovsky I. (2002). CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int. J. Cancer 98, 199-204.

  247. Blair, E., Redwood, C., de Jesus Oliveira, M., Moolman-Smook, J.C., Brink, P., Corfield, V.A., Ostman-Smith, I., Watkins, H. (2002). Mutations of the light meromyosin domain of the B-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ. Res. 90, 263-269.

  248. Bitoun, E., Chavanas, S., Irvine, A.D., Lonie, L., Bodemer, C., Paradisi, M., Hamel-Teillac, D., Ansai, S., Mitsuhashi, Y., Taieb, A., de Prost, Y., Zambruno, G., Harper, J.I., Hovnanian, A. (2002). Netherton Syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J. Invest. Dermatol. 118, 352-361.

  249. Ward, C.J., Hogan, M. C., Rossetti, S., Walker, D., Sneddon, T., Wang, X., Kubly, V., Cunningham, J.M., Bacallao, R., Ishibashi, M., Milliner, D.S., Torres, V.E., Harris, P.C. (2002). The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 30, 1-11.

  250. Vatta, M., Dumaine, R., Varghese, G., Richard, T.A., Shimizu, W., Aihara, N., Bademanee, K., Brugada, R., Brugada, J., Veerakul, G., Li, H., Bowles, N.E., Brugada, P., Antzelevitch, C., Towbin, J.A. (2002). Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum. Mol. Genet. 11, 337-345.

  251. Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M. (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder.Hum. Mol. Genet. 11, 961-969.

  252. Bienvenu T, Poirier K, Friocourt G, Bahi N, Beaumont D, Fauchereau F, Ben Jeema L, Zemni R, Vinet MC, Francis F, Couvert P, Gomot M, Moraine C, van Bokhoven H, Kalscheuer V, Frints S, Gecz J, Ohzaki K, Chaabouni H, Fryns JP, Desportes V, Beldjord C, Chelly J. (2002) ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation.Hum. Mol. Genet. 11, 981-991.

  253. Wang Z, Li H, Moss AJ, Robinson J, Zareba W, Knilans T, Bowles NE, Towbin JA. (2002) Compound heterozygous mutations in KvLQT1 cause Jervell and Lange-Nielsen syndrome.Mol. Genet. Metab. 75, 308-316.

  254. Bardwell PD, Martin A, Scharff MD. (2002) Mutation detection of immunoglobulin V-regions by DHPLC. J Immunol Methods. Aug 1;266(1-2):165-73.

  255. Su Z, Zhang S, Hou Y, Zhang L, Liao L, Xiao C. (2002) Relationship between a novel polymorphism of lipoprotein lipase gene and coronary heart disease. Chin Med J (Engl). 2002 May;115(5):677-80.

  256. Baldinu P, Cossu A, Manca A, Satta MP, Pisano M, Casula M, Dessole S, Pintus A, Tanda F, Palmieri G. (2002). Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma. Cancer 94, 3157-3168.

  257. Phillips HM, Renforth GL, Spalluto C, Hearn T, Curtis AR, Craven L, Havarani B, Clement-Jones M, English C, Stumper O, Salmon T, Hutchinson S, Jackson MS, Wilson DI. (2002). Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis. Genomics 79, 475-478.

  258. Dermaut B, Theuns J, Sleegers K, Hasegawa H, Van den Broeck M, Vennekens K, Corsmit E, St George-Hyslop P, Cruts M, van Duijn CM, Van Broeckhoven C. (2002). The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample. Am. J. Hum. Genet. 70, 1568-1574.

  259. Real FX, Malats N, Lesca G, Porta M, Chopin S, Lenoir GM, Sinilnikova O; PANKRAS II Study Group. (2002). Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer. Gut 50, 653-657.

  260. Lichtner P, Attie-Bitach T, Schuffenhauer S, Henwood J, Bouvagnet P, Scambler PJ, Meitinger T, Vekemans M. (2002). Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10p. J. Mol. Med. 80, 431-442.

  261. Brown VL, Proby CM, Barnes DM, Kelsell DP. (2002). Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours. Br. J. Cancer 87, 208-211.

  262. Sossey-Alaoui K, Kitamura E, Head K, Cowell JK. (2002). Characterization of FAM10A4, a member of the ST13 tumor suppressor gene family that maps to the 13q14.3 region associated with B-cell leukemia, multiple myeloma, and prostate cancer. Genomics 80, 5-7.

  263. Ackerman MJ, VanDriest SL, Ommen SR, Will ML, Nishimura RA, Tajik AJ, Gersh BJ. (2002). Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J. Am. Coll. Cardiol. 39, 2042-2048.

  264. De la Cruz JM, Bamford RN, Burdine RD, Roessler E, Barkovich AJ, Donnai D, Schier AF, Muenke M. (2002). A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects. Hum. Genet. 110, 422-429.

  265. Morrison D, FitzPatrick D, Hanson I, Williamson K, van Heyningen V, Fleck B, Jones I, Chalmers J, Campbell H. (2002). National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology. J. Med. Genet. 39, 16-22.

  266. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR. (2002). Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. Proc. Natl. Acad. Sci. 99, 9433-9438.

  267. Kosaki K, Suzuki T, Muroya K, Hasegawa T, Sato S, Matsuo N, Kosaki R, Nagai T, Hasegawa Y, Ogata T. (2002) PTPN11 (Protein-Tyrosine Phosphatase, Nonreceptor-Type 11) Mutations in Seven Japanese Patients with Noonan Syndrome. J Clin Endocrinol Metab. 2002 Aug;87(8):3529-33.

  268. Hegde M, Lewis RA, Richards CS. (2002) Diagnostic DNA testing for X-linked ocular albinism (OA1) with a hierarchical mutation screening protocol. Genet Test. Spring;6(1):7-14

  269. Bogdanova N, Markoff A, Pollmann H, Nowak-Gottl U, Eisert R, Dworniczak B, Eigel A, Horst J. (2002) Prevalence of small rearrangements in the factor VIII gene F8C among patients with severe hemophilia A. Hum Mutat. Sep;20(3):236-7.

  270. Kang HC, Kim IJ, Park JH, Kwon HJ, Won YJ, Heo SC, Lee SY, Kim KH, Shin Y, Noh DY, Yang DH, Choe KJ, Lee BH, King SB, Park JG. (2002) Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. Hum Mutat.Sep;20(3):235.

  271. Frusconi S, Passerini I, Girolami F, Masieri M, Linari S, Longo G, Morfini M, Torricelli F. (2002) Identification of seven novel mutations of F8C by DHPLC. Hum Mutat.Sep;20(3):231-2.

  272. Shen P, Buchholz M, Sung R, Roxas A, Franco C, Yang WH, Jagadeesan R, Davis K, Oefner PJ. (2002) Population genetic implications from DNA polymorphism in random human genomic sequences. Hum Mutat. Sep;20(3):209-217.

  273. Yoshida N, Nishimaki Y, Sugiyama M, Abe T, Tatsumi T, Tanoue A, Hirasawa A, Tsujimoto G. (2002) SNP genotyping in the beta(2)-adrenergic receptor by electronic microchip assay, DHPLC, and direct sequencing. J Hum Genet.;47(9):500-3.

  274. Edmunds SC, Kelsell DP, Hungerford JL, Cree IA. (2002) Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Invest Ophthalmol Vis Sci. Sep;43(9):2845-51.

  275. Gorlov IP, Kamat A, Bogatcheva NV, Jones E, Lamb DJ, Truong A, Bishop CE, McElreavey K, Agoulnik AI. (2002) Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet. Sep 15;11(19):2309-2318.

  276. Weirich G, Cabras A, Serra S, Coni P, Nurchi A, Faa G, Hofler H. (2002). Rapid Identification of Wilson's Disease Carriers by Denaturing High-Performance Liquid Chromatography. Prev. Med. 35, 278-284.

  277. Gavert N, Yaron Y, Naiman T, Bercovich D, Rozen P, Shomrat R, Legum C, Orr-Urtreger A. (2002). Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum. Mutat. 19, 664.

  278. Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP. (2002). PTPN11 mutations in LEOPARD syndrome. J. Med. Genet. 39, 571-574.

  279. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. (2002). Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21, 4863-4871.

  280. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. (2002). PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70, 1555-1563.

  281. Lam CW, Leung CY, Lee KC, Xie J, Lo FM, Au TS, Tong SF, Poon MK, Chan LY, Luk NM. (2002). Novel mutations in the PATCHED gene in basal cell nevus syndrome. Mol. Genet. Metab. 76, 57-61.

  282. Venken K, Di Maria E, Bellone E, Balestra P, Cassandrini D, Mandich P, De Jonghe P, Timmerman V, Svaren J. (2002). Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies. Neurogenetics 4, 37-41.

  283. Varon R, Gosse-Brun S, Bignon YJ, Sperling K, Uhrhammer N. (2002). Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinoma. Oncol. Rep. 9, 709-711

  284. Gallo A, Thomson E, Brindle J, O'Connell MA, Keegan LP. (2002) Micro-processing events in mRNAs identified by DHPLC analysis.Nucleic Acids Res. Sep 15;30(18):3945-53.

  285. Dode C, Andre M, Bienvenu T, Hausfater P, Pecheux C, Bienvenu J, Lecron JC, Reinert P, Cattan D, Piette JC, Szajnert MF, Delpech M, Grateau G; French Heraditary Recurrent Inflammatory Disorder Study Group. (2002). The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis & Rheumatism 46, 2181-2188.

  286. Su Z, Zhang S, Nebert DW, Zhang L, Huang D, Hou Y, Liao L, Xiao C. (2002). A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity. J Lipid Res 43:1595-1601.

  287. Schollen E, Martens K, Geuzens E, Matthijs G. (2002). DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG). Eur J Hum Genet 10:643-648.

  288. Hanein S, Perrault I, Olsen P, Lopponen T, Hietala M, Gerber S, Jeanpierre M, Barbet F, Ducroq D, Hakiki S, Munnich A, Rozet JM, Kaplan J. (2002). Evidence of a founder effect for the RETGC1 (GUCY2D) 2943delG mutation in Leber congenital amaurosis pedigrees of Finnish origin. Hum Mutat. 2002 Oct;20(4):322-3

  289. Yaron Y, Zeev BB, Shomrat R, Bercovich D, Naiman T, Orr-Urtreger A. (2002). MECP2 mutations in Israel: Implications for molecular analysis, genetic counseling, and prenatal diagnosis in Rett syndrome. Hum Mutat. 2002 Oct;20(4):323-4

  290. Lie BA, Akselsen HE, Bowlus CL, Gruen JR, Thorsby E, Undlien DE. (2002). Polymorphisms in the gene encoding thymus-specific serine protease in the extended HLA complex: a potential candidate gene for autoimmune and HLA-associated diseases. Genes Immun. 3, 306-312.

  291. Bray NJ, Kirov G, Owen RJ, Jacobsen NJ, Georgieva L, Williams HJ, Norton N, Spurlock G, Jones S, Zammit S, O'Donovan MC, Owen MJ. (2002). Screening the human protcadherin 8 (PCDH8) gene in schizophrenia. Genes, Brain and Behavior 1, 187-191.

  292. Audrezet MP, Chen JM, Le Marechal C, Ruszniewski P, Robaszkiewicz M, Raguenes O, Quere I, Scotet V, Ferec C. (2002). Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 10:100-106.

  293. Lynch RA, Wagoner L, Li S, Sparks L, Molkentin J, Dorn GW 2nd. (2002). Novel and nondetected human signaling protein polymorphisms. Physiol Genomics 10, 159-168.

  294. Roberts PS, Chung J, Jozwiak S, Dabora SL, Franz DN, Thiele EA, Kwiatkowski DJ. (2002). SNP identification, haplotype analysis, and parental origin of mutations in TSC2. Hum Genet 111:96-101.

  295. Fields RR, Zhou G, Huang D, Davis JR, Moller C, Jacobson SG, Kimberling WJ, Sumegi J. (2002). Usher Syndrome Type III: Revised Genomic Structure of the USH3 Gene and Identification of Novel Mutations. Am J Hum Genet 71:607-617.

  296. Jones I, Jacobsen N, Green EK, Elvidge GP, Owen MJ, Craddock N. (2002). Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease. Mol Psychiatry 7:424-427.

  297. Pallares-Ruiz N, Blanchet P, Mondain M, Claustres M, Roux AF. (2002). A large deletion including most of GJB6 in recessive non syndromic deafness: a digenic effect? Eur J Hum Genet 10:72-76.

  298. Devaney JM, Donarum EA, Brown KM, Meyer J, Stober G, Lesch KP, Nestadt G, Stephan DA, Pulver AE. (2002). No missense mutation of WKL1 in a subgroup of probands with schizophrenia. Mol Psychiatry 7:419-423.

  299. Bepler G, Gautam A, McIntyre LM, Beck AF, Chervinsky DS, Kim YC, Pitterle DM, Hyland A. (2002). Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J Clin Oncol 20, 1353-1360.

  300. Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, Sekido Y, Minna JD, Sone S, Yokota J. (2002). MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc. Natl. Acad. Sci. 99, 12269-12274.

  301. Yamamoto N, Nakayama J, Yamakawa-Kobayashi K, Hamaguchi H, Miyazaki R, Arinami T. (2002). Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum. Mutat. 19, 251-257.

  302. Sossey-Alaoui K, Su G, Malaj E, Roe B, Cowell JK. (2002). WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t(1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene 21, 5967-5974.

  303. Anney RJ, Rees MI, Bryan E, Spurlock G, Williams N, Norton N, Williams H, Cardno A, Zammit S, Jones S, Jones G, Hoogendoorn B, Smith K, Hamshere ML, Coleman S, Guy C, O'Donovan MC, Owen MJ, Buckland PR. (2002). Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia. Mol. Psychiatry 7, 493-502.

  304. Bonora E, Bacchelli E, Levy ER, Blasi F, Marlow A, Monaco AP, Maestrini E; International Molecular Genetic Study of Autism Consortium (IMGSAC). (2002). Mutation screening and imprinting analysis of four candidate genes for autism in the 7q32 region. Mol. Psychiatry 7, 289-301.

  305. Williams NM, Bowen T, Spurlock G, Norton N, Williams HJ, Hoogendoorn B, Owen MJ, O'Donovan MC. (2002). Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Mol. Psychiatry 7, 508-514.

  306. Rudolph G, Kalpadakis P, Haritoglou C, Rivera A, Weber BH. (2002). Mutations in the ABCA4 Gene in a Family With Stargardt's Disease and Retinitis Pigmentosa (STGD1/RP19). Klin Monatsbl Augenheilkd 219:590-596.

  307. Marchant D, Gogat K, Dureau P, Sainton K, Sternberg C, Gadin S, Dollfus H, Brasseur G, Hache J, Dumur V, Puech V, Munier F, Schorderet D, Marsac C, Menasche M, Dufier J, Abitbol M. (2002). Use of denaturing HPLC and automated sequencing to screen the VMD2 gene for mutations associated with Best's vitelliform macular dystrophy. Ophthalmic Genet 23:167-174.

  308. Challa P, Herndon LW, Hauser MA, Broomer BW, Pericak-Vance MA, Ababio-Danso B, Allingham RR. (2002). Prevalence of Myocilin Mutations in Adults with Primary Open-angle Glaucoma in Ghana, West Africa. J Glaucoma 11:416-420.

  309. Ion A, Tartaglia M, Song X, Kalidas K, Van Der Burgt I, Shaw AC, Ming JE, Zampino G, Zackai EH, Dean JC, Somer M, Parenti G, Crosby AH, Patton MA, Gelb BD, Jeffery S. (2002) Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome. Hum Genet. Oct;111(4-5):421-7.

  310. Huang H, Zhou YF, Jiang PZ, Shen XM, Yao KT. (2002) Screening of single nucleotide polymorphisms in nasopharyngeal carcinoma associated genes by denaturing high-performance liquid chromatography. Di Yi Jun Yi Da Xue Xue Bao. Jul;22(7):602-4

  311. Bernassola F, Federici M, Corazzari M, Terrinoni A, Hribal ML, De Laurenzi V, Ranalli M, Massa O, Sesti G, McLean WH, Citro G, Barbetti F, Melino G. (2002). Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J 16, 1371-1378.

  312. Raevaara TE, Timoharju T, Lonnqvist KE, Kariola R, Steinhoff M, Hofstra RM, Mangold E, Vos YJ, Nystrom-Lahti M. (2002). Description and functional analysis of a novel in frame mutation linked to hereditary non-polyposis colorectal cancer. J. Med. Genet. 39, 747-750.

  313. Hamaguchi M, Meth JL, Von Klitzing C, Wei W, Esposito D, Rodgers L, Walsh T, Welcsh P, King MC, Wigler MH. (2002). DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc. Natl. Acad. Sci. 99, 13647-13652.

  314. Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, Thomson W, Ray D. (2002). Mutation screening of the macrophage migration inhibitory factor gene: Positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis & Rheumatism 46, 2402-2409.

  315. Rennert H, Bercovich D, Hubert A, Abeliovich D, Rozovsky U, Bar-Shira A, Soloviov S, Schreiber L, Matzkin H, Rennert G, Kadouri L, Peretz T, Yaron Y, Orr-Urtreger A. (2002). A Novel Founder Mutation in the RNASEL Gene, 471delAAAG, Is Associated with Prostate Cancer in Ashkenazi Jews. Am. J. Hum. Genet. 71, 981-984.

  316. Halliday DJ, Hutchinson S, Lonie L, Hurst JA, Firth H, Handford PA, Wordsworth P. (2002). Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice. J. Med. Genet. 39, 589-593.

  317. Jongbloed R, Marcelis C, Velter C, Doevendans P, Geraedts J, Smeets H. (2002) DHPLC analysis of potassium ion channel genes in congenital long QT syndrome. Hum Mutat. 2002 Nov;20(5):382-91.

  318. Bodamer OA, Bercovich D, Schlabach M, Ballantyne C, Zoch D, Beaudet AL. (2002) Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clin Chem 48:1913-1918.

  319. Pfeiffer RM, Bura E, Smith A, Rutter JL. (2002). Two approaches to mutation detection based on functional data. Stat Med 21(22):3447-3464.

  320. Sutomo R, Akutsu T, Takeshima Y, Nishio H, Sadewa AH, Harada Y, Matsuo M. (2002). Rapid SMN1 deletion test using DHPLC to screen patients with spinal muscular atrophy. Am J Med Genet 113(2):225-226.

  321. Beyer KS, Blasi F, Bacchelli E, Klauck SM, Maestrini E, Poustka A. (2002). Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet 111:305-309.

  322. Weirich G, Klein B, Wohl T, Engelhardt D, Brauch H. (2002) VHL2C Phenotype in a German von Hippel-Lindau Family with Concurrent VHL Germline Mutations P81S and L188V. J Clin Endocrinol Metab.Nov;87(11):5241-5246.

  323. Dobson-Stone C, Danek A, Rampoldi L, Hardie RJ, Chalmers RM, Wood NW, Bohlega S, Dotti MT, Federico A, Shizuka M, Tanaka M, Watanabe M, Ikeda Y, Brin M, Goldfarb LG, Karp BI, Mohiddin S, Fananapazir L, Storch A, Fryer AE, Maddison P, Sibon I, Trevisol-Bittencourt PC, Singer C, Caballero IR, Aasly JO, Schmierer K, Dengler R, Hiersemenzel LP, Zeviani M, Meiner V, Lossos A, Johnson S, Mercado FC, Sorrentino G, Dupre N, Rouleau GA, Volkmann J, Arpa J, Lees A, Geraud G, Chouinard S, Nemeth A, Monaco. (2002). Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur. J. Hum. Genet. 10, 773-781.

  324. Johnson GC, Payne F, Nutland S, Stevens H, Tuomilehto-Wolf E, Tuomilehto J, Todd JA. (2002). A comprehensive, statistically powered analysis of GAD2 in type 1 diabetes. Diabetes 51, 2866-2870.

  325. Farook VS, Hanson RL, Wolford JK, Bogardus C, Prochazka M. (2002). Molecular Analysis of KCNJ10 on 1q as a Candidate Gene for Type 2 Diabetes in Pima Indians. Diabetes 51:3342-3346.

  326. Turner KJ, Moore JW, Jones A, Taylor CF, Cuthbert-Heavens D, Han C, Leek RD, Gatter KC, Maxwell PH, Ratcliffe PJ, Cranston D, Harris AL. (2002). Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62:2957-2961.

  327. Wu FF, Ryan A, Devaney J, Warnstedt M, Korade-Mirnics Z, Poser B, Escriva MJ, Pegoraro E, Yee AS, Felice KJ, Giuliani MJ, Mayer RF, Mongini T, Palmucci L, Marino M, Rudel R, Hoffman EP, Fahlke C. (2002). Novel CLCN1 mutations with unique clinical and electrophysiological consequences. Brain 125:2392-2407.

  328. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP. (2002) Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet. Feb;30(2):227-32.

  329. Ross JL, Scott C Jr, Marttila P, Kowal K, Nass A, Papenhausen P, Abboudi J, Osterman L, Kushner H, Carter P, Ezaki M, Elder F, Wei F, Chen H, Zinn AR. (2002). Phenotypes Associated with SHOX Deficiency. J. Clin. Endocrinol. Metab. 86, 5674-5680.

  330. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P. (2002). Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet. 11, 2607-2614.

  331. Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR, Cheadle JP. (2002). Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum. Mol. Genet. 11, 2961-2967.

  332. Prueitt RL, Chen H, Barnes RI, Zinn AR. (2002). Most X; autosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenet. Genome Res. 97, 32-38.

  333. Gorospe JR, Naidu S, Johnson AB, Puri V, Raymond GV, Jenkins SD, Pedersen RC, Lewis D, Knowles P, Fernandez R, De Vivo D, van der Knaap MS, Messing A, Brenner M, Hoffman EP. (2002). Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neuorology 58, 1494-1500.

  334. Wilkie H, Osei-Lah A, Chioza B, Nashef L, McCormick D, Asherson P, Makoff AJ. (2002). Association of micro -opioid receptor subunit gene and idiopathic generalized epilepsy. Neuorology 59, 724-728.

  335. Mazzei R, Conforti FL, Muglia M, Sprovieri T, Magariello A, Patitucci A, Gabriele AL, Quattrone A. (2002). A simple method to confirm diagnosis of autosomal recessive Spinal Muscular atrophy by Denaturing High Performance Liquid Chromatography (DHPLC). Am J Hum Genet 71 (Suppl):518.

  336. Christodoulou J, Biggin A, Thorburn DR, Bennetts B. (2002). Mutation scanning of the mitochondrial genome using denaturing high-performance liquid chromatography. Am J Hum Genet 71 (Suppl):427.

  337. De Luca A, Buccino A, Gianni D, Lazzarino AI, Mangino M, Giustini S, Richetta A, Divona L, Calvieri S, Mingarelli R, Dallapiccola B. (2002). NF1-gene analysis based on denaturing high-performance liquid chromatography (DHPLC). Am J Hum Genet 71 (Suppl):374.

  338. McWilliams S, Nelson T, Cavender M, Goldfarb L, Sivakumar K, Sambuughin N. (2002). Comprehensive screening of the RYR1 gene by denaturing high-performance liquid chromatography. Am J Hum Genet 71 (Suppl):547.

  339. Bayat A, Walter J, McAndrew P, Lamb H, Watson JS, Stanley JK, Marino M, Ferguson MWJ, Ollier WER. (2002). Identification of novel mitochondrial mutations in Dupuytrens disease using enhanced multiplex DHPLC. Am J Hum Genet 71 (Suppl):500.

  340. Walter J, Lamb H, Marino MA. (2002). High throughput mutation detection in the mitochondrial genome using DHPLC. Am J. Hum Genet 71 (Suppl):503.

  341. Prassad SD, Kolln KA, Cucci RA, Van Hauwe P, Coucke P, Trembath R, Van Camp G, Smith RJH. (2002). Mutation Screening of SLC26A4 by DHPLC. Am J Hum Genet 71 (Suppl):375.

  342. Kessler JZ, Matthews LJ, Hillman RE, Phillips CL. (2002). Carrier and newborn diagnostic test for the common Y438N maple syrup urine disease allele by DHPLC. Am J Hum Genet 71 (Suppl):411.

  343. Colosimo A, Guida V, Rigoli L, Di Bella C, De Luca A, Palka G, Salpietro DC, Dallapiccola B. (2002). Mutational screening of Italian Wolfram Syndrome patients by DHPLC. Am J Hum Genet 71 (Suppl):385.

  344. Elahi E, Alinasab B, Esson G, Ghassemi F, Houshmand M, Khodadad A, Oefner P, Reihani-Sabet F, Ronaghi M, Shahabi M, Thorstenson Y. (2002). Analysis of eight exons of the CFTR gene in 65 Iranian cystic fibrosis patients by DHPLC and sequencing. Am J Hum Genet 71 (Suppl):546.

  345. Ferec C, Rouault K, Audrezet MP, Le Marechal C. (2002). Improvement of the scanning of the CFTR gene by multiplexing DHPLC analysis. Am J Hum Genet 71 (Suppl):546.

  346. Hu X, Robin RW, Taubman J, Goldman D. (2002). Genotyping of the HTTLPR Ins/Del by dHPLC followed by association/linkage diseqilibrium to behavior in a Southwest American Indian isolate. Am J Hum Genet 71 (Suppl):505.

  347. Emmerson P, Maynard J, Butler R, Sampson JR, Cheadle JP. (2002). Characterisation of mutations in patients with low level mosaicism by fraction collection of dHPLC separated heteroduplex peaks. Am J Hum Genet 71 (Suppl):545.

  348. De Paula F, Vainzof M, Passos-Bueno MR, De Cassia M Pavanello R, Matioli SR, V B Anderson L, Nigro V, Zatz M. (2002) Clinical variability in calpainopathy: What makes the difference? Eur J Hum Genet. Dec;10(12):825-32.

  349. Arnold N, Peper H, Bandick K, Kreikemeier M, Karow D, Teegen B, Jonat W. (2002) Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. Dec 25;782(1-2):99-104.

  350. Muhr D, Wagner T, Oefner PJ. (2002) Polymerase chain reaction fidelity and denaturing high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. Dec 25;782(1-2):105-10.

  351. Heritage ML, MacMillan JC, Anderson GJ. (2002) DHPLC mutation analysis of Jagged1 (JAG1) reveals six novel mutations in Australian alagille syndrome patients. Hum Mutat. Dec;20(6):481.

  352. Karkera JD, Izraeli S, Roessler E, Dutra A, Kirsch I, Muenke M. (2002) The genomic structure, chromosomal localization, and analysis of SIL as a candidate gene for holoprosencephaly. Cytogenet Genome Res.;97(1-2):62-7.

  353. Van Driest SL, Will ML, Atkins DL, Ackerman MJ. (2002) A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.Am J Cardiol. Nov 15;90(10):1123-7.

  354. Wan J, Shi J, Hui L, Wu D, Jin X, Zhao N, Huang W, Xia Z, Hu G. (2002) The effect of weather on respiratory and cardiovascular deaths in 12 u.s. Cities. Environ Health Perspect. Dec;110(12):1213-8.

  355. Gerth C, Andrassi-Darida M, Bock M, Preising MN, Weber BH, Lorenz B. (2002). Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Am J Hum Genet 240:628-638.

  356. Mackay DJ, Coupe AM, Shield JP, Storr JN, Temple IK, Robinson DO. (2002). Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus. Hum. Genet. 110, 139-144.

  357. Conte I, Lestingi M, den Hollander A, Miano MG, Alfano G, Circolo D, Pugliese M, Testa F, Simonelli F, Rinaldi E, Baiget M, Banfi S, Ciccodicola A. (2002). Characterization of MPP4, a gene highly expressed in photoreceptor cells, and mutation analysis in retinitis pigmentosa. Gene 297, 33-38.

  358. Liu Y, Dodds P, Emilion G, Mungall AJ, Dunham I, Beck S, Wells RS, Charnock FM, Ganesan TS. (2002). The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer. BMC Genet. 3, 20.

  359. Nakayama J, Yoshizawa T, Yamamoto N, Arinami T. (2002). Mutation analysis of the calpastatin gene (CAST) in patients with Alzheimer's disease. Neurosci. Lett. 320, 77-80.

  360. Tomizawa Y, Kohno T, Kondo H, Otsuka A, Nishioka M, Niki T, Yamada T, Maeshima A, Yoshimura K, Saito R, Minna JD, Yokota J. (2002). Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res 8:2362-2368.

  361. Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, Nishimura RA, Tajik AJ, Gersh BJ. (2002). Prevalence and Severity of "Benign" Mutations in the beta-Myosin Heavy Chain, Cardiac Troponin T, and alpha-Tropomyosin Genes in Hypertrophic Cardiomyopathy Circulation 106, 3085-3090.

  362. Vervoort VS, Viljoen D, Smart R, Suthers G, DuPont BR, Abbott A, Schwartz CE. (2002) Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype. J Med Genet. Dec;39(12):893-899.

  363. Toomajian C, Kreitman M. (2002). Sequence Variation and Haplotype Structure at the Human HFE Locus. Genetics 161, 1609-1623.

  364. Fornage M, Hinojos CA, Nurowska BW, Boerwinkle E, Hammock BD, Morisseau CH, Doris PA. (2002). Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats. Hypertension 40, 485-490.

  365. Luedecking-Zimmer E, DeKosky ST, Chen Q, Barmada MM, Kamboh MI. (2002). Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12. Hum. Genet. 111, 443-451.

  366. Cazzola M, Cremonesi L, Papaioannou M, Soriani N, Kioumi A, Charalambidou A, Paroni R, Romtsou K, Levi S, Ferrari M, Arosio P, Christakis J. (2002). Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br J Haematol 119, 539-546.

  367. Nickerson M, Warren M, Toro J, Matrosova V, Glenn G, Turner M, Duray P, Merino M, Choyke P, Pavlovich C, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman M, Linehan W, Zbar B, Schmidt L. (2002). Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2, 157-164.

  368. Stover EH, Borthwick KJ, Bavalia C, Eady N, Fritz DM, Rungroj N, Giersch AB, Morton CC, Axon PR, Akil I, Al-Sabban EA, Baguley DM, Bianca S, Bakkaloglu A, Bircan Z, Chauveau D, Clermont MJ, Guala A, Hulton SA, Kroes H, Li Volti G, Mir S, Mocan H, Nayir A, Ozen S, Rodriguez Soriano J, Sanjad SA, Tasic V, Taylor CM, Topaloglu R, Smith AN, Karet FE. (2002). Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet 39:796-803.

  369. Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC. (2002). Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Cancer Res. 62, 5906-5911.

  370. Terron-Kwiatkowski A, Paller AS, Compton J, Atherton DJ, McLean WH, Irvine AD. (2002). Two Cases of Primarily Palmoplantar Keratoderma Associated with Novel Mutations in Keratin 1. J. Invest. Dermatol. 119, 966-971.

  371. Hunter DS, Klotzbucher M, Kugoh H, Cai SL, Mullen JP, Manfioletti G, Fuhrman U, Walker CL. (2002). Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function. Cancer Res. 62, 3766-3772.

  372. Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D. (2002). Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430-6433.

  373. Howard HC, Mount DB, Rochefort D, Byun N, Dupre N, Lu J, Fan X, Song L, Riviere JB, Prevost C, Horst J, Simonati A, Lemcke B, Welch R, England R, Zhan FQ, Mercado A, Siesser WB, George AL, McDonald MP, Bouchard JP, Mathieu J, Delpire E, Rouleau GA. (2002). The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat. Genet. 32, 384-392.

  374. Scotet V, Gillet D, Dugueperoux I, Audrezet MP, Bellis G, Garnier B, Roussey M, Rault G, Parent P, De Braekeleer M, Ferec C, Reseau Mucoviscidose Bretagne Et Pays De Loire. (2002). Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960. Hum. Genet. 111, 247-254.

  375. Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Terrier-Lacombe MJ, Bressac De-Paillerets B, Barrois M, Feunteun J, Kirn DH, Vassal G. (2002). Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts. Cancer Res 62:764-772.

  376. Bettecken T, Rubie C, Lichtner P, Siekiera M, Meitinger T, Stober G. (2002) Reduced amplification efficiency of KIAA0027/MLC1 alleles: implications for the molecular diagnosis of megalencephalic leukoencephalopathy with subcortical cysts. Mol Cell Probes. Oct;16(5):379-84.

  377. Williams NM, Spurlock G, Norton N, Williams HJ, Hamshere ML, Krawczak M, Kirov G, Nikolov I, Georgieva L, Jones S, Cardno AG, O'Donovan MC, Owen MJ. (2002) Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach. Mol Psychiatry 7(10):1092-100.

  378. Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR. (2002). NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J. Clin. Invest. 110, 1659-1666.

  379. Malacarne M, Madia F, Gennaro E, Vacca D, Guney AI, Buono S, Bernardina BD, Gaggero R, Gobbi G, Lispi ML, Malamaci D, Melideo G, Roccella M, Sferro C, Tiberti A, Vanadia F, Vigevano F, Viri F, Vitali MR, Bricarelli FD, Bianchi A, Zara F. (2002). Lack of SCN1A mutations in familial febrile seizures. Epilepsia 43, 559-562.

  380. Suzuki T, Morita R, Sugimoto Y, Sugawara T, Bai DS, Alonso ME, Medina MT, Bailey JN, Rasmussen A, Ramos-Peek J, Cordova S, Rubio-Donnadieu F, Ochoa A, Jara-Prado A, Inazawa J, Delgado-Escueta AV, Yamakawa K. (2002). Identification and mutational analysis of candidate genes for juvenile myoclonic epilepsy on 6p11-p12: LRRC1, GCLC, KIAA0057 and CLIC5. Epilepsy Res. 50, 265-275.

  381. Hunt JD, Strimas A, Martin JE, Eyer M, Haddican M, Luckett BG, Ruiz B, Axelrad TW, Backes WL, Fontham ET. (2002). Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens. Cancer Epidemiol. Biomarkers Prev. 11, 1405-1412.

  382. Eurlings PM, van der Kallen CJ, Geurts JM, Flavell DM, de Bruin TW. (2002). Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia. Mol. Genet. Metab. 77, 274-281.

  383. Zanger UM, Fischer J, Klein K, Lang T. (2002). Detection of single nucleotide polymorphisms in CYP2B6 gene. Methods Enzymol 357, 45-53.

  384. Rubie C, Lichtner P, Gartner J, Siekiera M, Uziel G, Kohlmann B, Kohlschutter A, Meitinger T, Stober G, Bettecken T. (2002). Sequence diversity of KIAA0027/MLC1: are megalencephalic leukoencephalopathy and schizophrenia allelic disorders? Hum. Mutat. 21, 45-52.

  385. Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J. (2002). Rare Variants of ATM and Risk for Hodgkin's Disease and Radiation-associated Breast Cancers. Clin. Cancer Res. 8, 3813-3819.

  386. De Paula F, Vainzof M, Passos-Bueno MR, De Cassia M Pavanello R, Matioli SR, V B Anderson L, Nigro V, Zatz M. (2002). Clinical variability in calpainopathy: What makes the difference? Eur. J. Hum. Genet. 10, 825-832.

  387. Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, Marcus V, Tomsho L, Gebert J, Macrae FA, Gaff CL, Paillerets BB, Gregersen PK, Weitzel JN, Gordon PH, MacNamara E, King MC, Hampel H, De La Chapelle A, Boyd J, Offit K, Rennert G, Chong G, Ellis NA. (2002). The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am. J. Hum. Genet. 71, 1395-1412.

  388. Burchell A, Forsyth L, Hume R. (2002) Polymorphisms in genes involved in glucose metabolism in cases of sudden infant death syndrome. Child Care Health Dev. Sep;28 Suppl 1:37-9.

  389. Young J, Barker M, Fraser L, Walsh MD, Spring K, Biden KG, Hopper JL, Leggett BA, Jass JR. (2002) Mutation searching in colorectal cancer studies: experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes. Pathology. Dec;34(6):529-33.

  390. Nelis E, Erdem S, Tan E, Lofgren A, Ceuterick C, De Jonghe P, Van Broeckhoven C, Timmerman V, Topaloglu H. (2002). A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheaths. Neuromuscul. Disord. 12, 869-873.

  391. Valdivia CR, Ackerman MJ, Tester DJ, Wada T, McCormack J, Ye B, Makielski JC. (2002). A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine. Cardiovasc. Res. 55, 279-289.

  392. Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, Tavazzi L. (2002). Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J. Am. Coll. Cardiol. 39, 981-990.

  393. Wang JB, Ren HY, Li D, Sun Q, Lu DP. (2002) Frequency of Donor TNF-alpha Gene Polymorphism in Patients with Graft Versus Host Disease Following Hematopoietic Stem Cell Transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. Apr;10(2):133-7. Chinese.

  394. Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Clark AG, Herskowitz I, Giacomini KM; Pharmacogenetics of Membrane Transporters Investigators. (2002). Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 12, 395-405.

  395. Francks C, Fisher SE, Olson RK, Pennington BF, Smith SD, DeFries JC, Monaco AP. (2002). Fine mapping of the chromosome 2p12-16 dyslexia susceptibility locus: quantitative association analysis and positional candidate genes SEMA4F and OTX1. Psychiatr. Genet. 12, 35-41.

  396. Furuno T, Landi MT, Ceroni M, Caporaso N, Bernucci I, Nappi G, Martignoni E, Schaeffeler E, Eichelbaum M, Schwab M, Zanger UM. (2002). Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics 12, 529-534.

  397. Humbert M, Deng Z, Simonneau G, Barst RJ, Sitbon O, Wolf M, Cuervo N, Moore KJ, Hodge SE, Knowles JA, Morse JH. (2002). BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur. Respir. J. 20, 518-523.

  398. Xu E, Jia J, Sun W. (2002) [Mutation site of presenilin-1 gene in familial Alzheimer's disease] Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1518-20. Chinese.

  399. Schrijver I, Liu W, Odom R, Brenn T, Oefner P, Furthmayr H, Francke U. (2002). Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes. Am J Hum Genet 71:223-237.

  400. Schrijver I, Schievink WI, Godfrey M, Meyer FB, Francke U. (2002). Spontaneous spinal cerebrospinal fluid leaks and minor skeletal features of Marfan syndrome: a microfibrillopathy. J Neurosurg 96:483-489.

  401. Gross E, Seck K, Kiechle M. (2002) [Mutations in the dihydropyrimidine dehydrogenase gene and their role in 5-fluororuracil intolerance]. Zentralbl Gynakol. 2002 Dec;124(12):574-9. 

  402. Gross E, Seck K, Kiechle M. (2002) [Mutations in the dihydropyrimidine dehydrogenase gene and their role in 5-fluororuracil intolerance]. Zentralbl Gynakol. 2002 Dec;124(12):574-9.

  403. Urbanek M, Du Y, Silander K, Collins FS, Steppan CM, Strauss JF 3rd, Dunaif A, Spielman RS, Legro RS. (2003). Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 52, 214-217.

  404. Offit K, Heather P, Kirchhoff T, Prema K, Rapaport B, Gregersen P, Johnson S, Yossepowitch O, Huang H, Satagopan J, Robson M, Scheuer L, Nafa K, Ellis N. (2003). Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Genet. 4, epub.

  405. Li A, Davila S, Furu L, Qian Q, Tian X, Kamath PS, King BF, Torres VE, Somlo S. (2003). Mutations in PRKCSH Cause Isolated Autosomal Dominant Polycystic Liver Disease. Am. J. Hum. Genet. 72, epub.

  406. Schollen E, Matthijs G, Gewillig M, Fryns JP, Legius E. (2003). PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning. Eur. J. Hum. Genet. 11, 85-88.

  407. Deng DJ, Zhou J, Zhu BD, Ji JF, Harper JC, Powell SM. (2003) Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol. Jan;9(1):26-9.

  408. Zhao XR, Kang LC, Zhou YS, Jia YX, Chen Z, Kang SH, Li WM, Zhao M, Cui JT, Sun AL, Lu YY. (2003) Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration. Ai Zheng. Jan;22(1):50-4. Chinese.

  409. Mellai M, Giordano M, D'Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, Leone M, Ferro I, Liguori M, Trojano M, Ballerini C, Massacesi L, Cannoni S, Bomprezzi R, Momigliano-Richiardi P. (2003) Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum Immunol. Feb;64(2):274-84.

  410. Romano V, Cali F, Ragalmuto A, D'Anna RP, Flugy A, De Leo G, Giambalvo O, Lisa A, Fiorani O, Di Gaetano C, Salerno A, Tamouza R, Charron D, Zei G, Matullo G, Piazza A. (2003) Autosomal microsatellite and mtDNA genetic analysis in Sicily (Italy). Ann Hum Genet. Jan;67(Pt 1):42-53.

  411. Luc AD, Buccino A, Gianni D, Mangino M, Giustini S, Richetta A, Divona L, Calvieri S, Mingarelli R, Dallapiccola B. (2003) NF1 gene analysis based on DHPLC. Hum Mutat. Feb;21(2):171-2.

  412. Winter J, Lehmann T, Suckow V, Kijas Z, Kulozik A, Kalscheuer V, Hamel B, Devriendt K, Opitz J, Lenzner S, Ropers HH, Schweiger S. (2003) Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome. Hum Genet. 2003, epub

  413. Fricke E, Keller G, Becker I, Rosivatz E, Schott C, Plaschke S, Rudelius M, Hermannstadter C, Busch R, Hofler H, Becker KF, Luber B. (2003) Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma. Int J Cancer. 2003 Mar 10;104(1):60-5.

  414. Tezak Z, Prandini P, Boscaro M, Marin A, Devaney J, Marino M, Fanin M, Trevisan CP, Park J, Tyson W, Finkel R, Garcia C, Angelini C, Hoffman EP, Pegoraro E. (2003) Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha2 (LAMA2) deficiency. Hum Mutat. Feb;21(2):103-11.

  415. Gross E, Seck K, Neubauer S, Mayr J, Hellebrand H, Ratanaphan A, Lutz V, Stockinger H, Kiechle M. (2003). High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism. Int J Oncol. Feb;22(2):325-32

  416. Ray PF, Benit P, Bonnefont JP, Munnich A. (2003) Chronology of reported denaturing high performance liquid chromatography (DHPLC)-based prenatal diagnoses. Prenat Diagn. Jan;23(1):81.

  417. Auerbach AD, Greenbaum J, Pujara K, Batish SD, Bitencourt MA, Kokemohr I, Schneider H, Lobitzc S, Pasquini R, Giampietro PF, Hanenberg H, Levran O. (2003) Spectrum of sequence variation in the FANCG gene: An International Fanconi Anemia Registry (IFAR) study. Hum Mutat. Feb;21(2):158-68.

  418. Emmerson P, Maynard J, Jones S, Butler R, Sampson JR, Cheadle JP. (2003) Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes. Hum Mutat. 2003 Feb;21(2):112-5.

  419. Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, Martin JJ, Butler IJ, Mancias P, Papasozomenos SC, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, Timmerman V. (2003). Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126, 590-597.

  420. Khaliq S, Abid A, Hameed A, Anwar K, Mohyuddin A, Azmat Z, Shami SA, Ismail M, Mehdi SQ. (2003). Mutation screening of Pakistani families with congenital eye disorders. Exp. Eye Res. 76, 343-348.

  421. Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, Von Der Ohe M, Swillen A, Maes C, Gewillig M, Molin DG, Hellings P, Boetel T, Haardt M, Compernolle V, Dewerchin M, Plaisance S, Vlietinck R, Emanuel B, Gittenberger-De Groot AC, Scambler P, Morrow B, Driscol DA, Moons L, Esguerra CV, Carmeliet G, Behn-Krappa A, Devriendt K, Collen D, Conway SJ, Carmeliet P. (2003). VEGF: A modifier of the del22q11 (DiGeorge) syndrome? Nat. Med. 9, 173-182.

  422. Upadhyaya M, Majounie E, Thompson P, Han S, Consoli C, Krawczak M, Cordeiro I, Cooper DN. (2003). Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1. Hum Genet 112:12-17.

  423. Ginolhac SM, Gad S, Corbex M, Bressac-De-Paillerets B, Chompret A, Bignon YJ, Peyrat JP, Fournier J, Lasset C, Giraud S, Muller D, Fricker JP, Hardouin A, Berthet P, Maugard C, Nogues C, Lidereau R, Longy M, Olschwang S, Toulas C, Guimbaud R, Yannoukakos D, Szabo C, Durocher F, Moisan AM, Simard J, Mazoyer S, Lynch HT, Goldgar D, Stoppa-Lyonnet D, Lenoir GM, Sinilnikova OM. (2003). BRCA1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA1 Germ-Line Mutations. Cancer Epidemiol. Biomarkers Prev. 12, 90-95.

  424. Biancalana V, Caron O, Gallati S, Baas F, Kress W, Novelli G, D'Apice MR, Lagier-Tourenne C, Buj-Bello A, Romero NB, Mandel JL. (2003) Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum. Genet. 112, 135-142.

  425. Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, Qian C, Marks AF, Slager SL, Peterson BJ, Smith DI, Cheville JC, Blute ML, Jacobsen SJ, Schaid DJ, Tindall DJ, Thibodeau SN, Liu W. (2003). Mutations in CHEK2 Associated with Prostate Cancer Risk. Am. J. Hum. Genet. 72, 270-280.

  426. Sebastiani G, Wallace DF, Lioumi M, Goutos I, Mitchell WA, Bomford AB, Dhillon AP, Dooley JS, Ragoussis J, Walker AP. (2003). Non HFE-related haemochromatosis: exclusion of the 1q21 zinc-iron regulated transporter-like (ZIRTL) gene in juvenile haemochromatosis. J. Hepatol. 38, 376-377.

  427. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. (2003). Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192-196.

  428. Hogan MC, Griffin MD, Rossetti S, Torres VE, Ward CJ, Harris PC. (2003). PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression. Hum. Mol. Genet. 12, 685-698.

  429. McIlroy D, Cartron PF, Tuffery P, Dudoit Y, Samri A, Autran B, Vallette FM, Debre P, Theodorou I. (2003). A triple-mutated allele of granzyme B incapable of inducing apoptosis. Proc. Natl. Acad. Sci. 100, 2562-2567.

  430. Wolford JK, Gruber JD, Ossowski VM, Vozarova B, Antonio Tataranni P, Bogardus C, Hanson RL. (2003). A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol. Genet. Metab. 78, 136-144.

  431. Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L. (2003). Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J. Am. Coll. Cardiol. 41, 771-780.

  432. Musante L, Kehl HG, Majewski F, Meinecke P, Schweiger S, Gillessen-Kaesbach G, Wieczorek D, Hinkel GK, Tinschert S, Hoeltzenbein M, Ropers HH, Kalscheuer VM. (2003). Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet 11:201-206.

  433. Mhatre A, Weld E, Lalwani A. (2003) Mutation analysis of Connexin 31 (GJB3) in sporadic non-syndromic hearing impairment. Clin Genet.Feb;63(2):154-159.

  434. Kim IJ, Park JH, Kang H, Kim KH, Kim JH, Ku JL, Kang SB, Park S, Lee JS, Park JG. Identification of a novel BMPR1A germline mutation in a Korean juvenile polyposis patient without SMAD4 mutation. Clin Genet. Feb;63(2):126-130.

  435. Pruhova S, Ek J, Lebl J, Sumnik Z, Saudek F, Andel M, Pedersen O, Hansen T. (2003) Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha. Diabetologia. Feb;46(2):291-5.

  436. Mehdi H, Manzi S, Desai P, Chen Q, Nestlerode C, Bontempo F, Strom SC, Zarnegar R, Kamboh MI. (2003) A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem. Jan;270(2):230-8.

  437. Hofer A, Hermans M, Kubassek N, Sitzer M, Funke H, Stogbauer F, Ivaskevicius V, Oldenburg J, Burtscher J, Knopp U, Schoch B, Wanke I, Hubner F, Deinsberger W, Meyer B, Boecher-Schwarz H, Poewe W, Raabe A, Steinmetz H, Auburger G. (2003). Elastin polymorphism haplotype and intracranial aneurysms are not associated in central europe. Stroke 34, 1207-1211.

  438. Tammaro A, Bracco A, Cozzolino S, Esposito M, Di Martino A, Savoia G, Zeuli L, Piluso G, Aurino S, Nigro V. (2003) Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles. Clin Chem. 2003 May;49(5):761-8.

  439. Thistlethwaite WA, Moses LM, Hoffbuhr KC, Devaney JM, Hoffman EP. (2003) Rapid Genotyping of Common MeCP2 Mutations with an Electronic DNA Microchip Using Serial Differential Hybridization. J Mol Diagn. May;5(2):121-6.

  440. Breton J, Sichel F, Abbas A, Marnay J, Arsene D, Lechevrel M. (2003) Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France). Mutagenesis. 2003 May;18(3):299-306.

  441. Mitchell M, Harrington P, Cutler J, Rangarajan S, Savidge G, Alhaq A. (2003) Eighteen unrelated patients with factor XI deficiency, four novel mutations and a 100% detection rate by denaturing high-performance liquid chromatography. Br J Haematol. 2003 May;121(3):500-2.

  442. Mhatre AN, Kim Y, Brodie HA, Lalwani AK. (2003) Macrothrombocytopenia and progressive deafness is due to a mutation in MYH9. Otol Neurotol. 2003 Mar;24(2):205-9.

  443. Castaldo G, Nardiello P, Bellitti F, Rocino A, Coppola A, di Minno G, Salvatore F. (2003) Denaturing HPLC procedure for factor IX gene scanning. Clin ChemMay;49(5):815-8.

  444. Fruchon S, Bensaid M, Borot N, Roth MP, Coppin H. (2003) Use of denaturing HPLC and a heteroduplex generator to detect the HFE C282Y mutation associated with genetic hemochromatosis. Clin Chem. May;49(5):822-4.

  445. Bowen DT, Frew ME, Rollinson S, Roddam PL, Dring A, Smith MT, Langabeer SE, Morgan GJ. (2003). CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication. Blood 101, 2770-2774.

  446. Cremonesi L, Paroni R, Foglieni B, Galbiati S, Fermo I, Soriani N, Belloli S, Ruggeri G, Biasiotto G, Cazzola M, Ferrari F, Ferrari M, Arosio P. (2003). Scanning mutations of the 5'UTR regulatory sequence of l-ferritin by denaturing high-performance liquid chromatography: identification of new mutations. Br. J. Haematol. 121, 173-179.

  447. Backstrom G, Taipalensuu J, Melhus H, Brandstrom H, Svensson AC, Artursson P, Kindmark A. (2003). Genetic variation in the ATP-binding Cassette Transporter gene ABCG2 (BCRP) in a Swedish population. Eur. J. Pharm. Sci. 18, 359-364.

  448. Bernstein JL, Teraoka S, Haile RW, Borresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P. (2003). Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum. Mutat. 21, 542-550.

  449. Szijan I, Rochefort D, Bruder C, Surace E, Machiavelli G, Dalamon V, Cotignola J, Ferreiro V, Campero A, Basso A, Dumanski JP, Rouleau GA. (2003). NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH. NeuroMolecular Med. 3, 41-52.

  450. Pause FG, Wacker P, Maillet P, Betts D, Sappino AP. (2003). ATM gene alterations in childhood acute lymphoblastic leukemias. Hum. Mutat. 21, 554.

  451. Todd RD, Lobos EA, Sun LW, Neuman RJ. (2003). Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: evidence for association of an intronic polymorphism with attention problems. Mol. Psychiatry 8, 103-108.

  452. Liu HX, Zhou XL, Liu T, Werelius B, Lindmark G, Dahl N, Lindblom A. (2003). The Role of hMLH3 in Familial Colorectal Cancer. Cancer Res. 63, 1894-1899.

  453. Markova D, Zou Y, Ringpfeil F, Sasaki T, Kostka G, Timpl R, Uitto J, Chu ML. (2003). Genetic Heterogeneity of Cutis Laxa: A Heterozygous Tandem Duplication within the Fibulin-5 (FBLN5) Gene. Am. J. Hum. Genet. 72, 998-1004.

  454. Madia F, Gennaro E, Cecconi M, Buti D, Capovilla G, Dalla Bernardina B, Elia M, Ferrari A, Fontana E, Gaggero R, Giannotta M, Giordano L, Granata T, La Selva L, Luisa Lispi M, Santucci M, Vanadia F, Veggiotti P, Vigliano P, Viri M, Dagna Bricarelli F, Bianchi A, Zara F. (2003). No evidence of GABRG2 mutations in severe myoclonic epilepsy of infancy. Epilepsy Res. 53, 196-200.

  455. Fantes J, Ragge NK, Lynch SA, McGill NI, Collin JR, Howard-Peebles PN, Hayward C, Vivian AJ, Williamson K, Van Heyningen V, FitzPatrick DR. (2003). Mutations in SOX2 cause anophthalmia. Nat. Genet. 33, 461-463.

  456. Heinritz W, Kujat A, Froster U. (2003). Detection of five new mutations in the APC gene using denaturing high-performance liquid chromatography. Clin. Genet. 63, 325-327.

  457. Brautigam S, Kujat A, Kirst P, Seidel J, Umit Luleyap H, Froster UG. (2003) DHPLC mutation analysis of phenylketonuria. Mol Genet Metab. Mar;78(3):205-10.

  458. Passarino G, Cavalleri GL, Stecconi R, Franceschi C, Altomare K, Dato S, Greco V, Luca Cavalli Sforza L, Underhill PA, de Benedictis G. (2003) Molecular variation of human HSP90alpha and HSP90beta genes in Caucasians. Hum Mutation May;21(5):554-5.

  459. Richard G, Brown N, Rouan F, Van der Schroeff JG, Bijlsma E, Eichenfield LF, Sybert VP, Greer KE, Hogan P, Campanelli C, Compton JG, Bale SJ, DiGiovanna JJ, Uitto J. (2003). Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations. J. Invest. Dermatol. 120, 601-609.

  460. Blaydon DC, Mueller RF, Hutchin TP, Leroy BP, Bhattacharya SS, Bird AC, Malcolm S, Bitner-Glindzicz M. (2003). The contribution of USH1C mutations to syndromic and non-syndromic deafness in the UK. Clin. Genet. 63, 303-307.

  461. Stanton T, Boxall S, Hirai K, Dawes R, Tonks S, Yasui T, Kanaoka Y, Yuldasheva N, Ishiko O, Bodmer W, Beverley PC, Tchilian EZ. (2003). A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression. Proc. Natl. Acad. Sci. 100, 5997-6002.

  462. State MW, Greally JM, Cuker A, Bowers PN, Henegariu O, Morgan TM, Gunel M, DiLuna M, King RA, Nelson C, Donovan A, Anderson GM, Leckman JF, Hawkins T, Pauls DL, Lifton RP, Ward DC. (2003). Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype. Proc. Natl. Acad. Sci. 100, 4684-4689.

  463. Vaughan CJ, Hom Y, Okin DA, McDermott DA, Lerman BB, Basson CT. (2003). Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome. J. Cardiovasc. Electrophysiol. 14, 263-268.

  464. Rickard SJ, Wilson LC. (2003). Analysis of GNAS1 and overlapping transcripts identifies the parental origin of mutations in patients with sporadic Albright hereditary osteodystrophy and reveals a model system in which to observe the effects of splicing mutations on translated and untranslated messenger RNA. Am. J. Hum. Genet. 72, 961-974.

  465. Lanzara C, Ficarella R, Totaro A, Chen X, Roberto R, Perrotta S, Lasalandra C, Gasparini P, Iolascon A, Carella M. (2003). Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes. Blood Cells Mol. Dis. 30, 22-29.

  466. Jaatinen T, Lahti M, Ruuskanen O, Kinos R, Truedsson L, Lahesmaa R, Lokki ML. (2003). Total C4B deficiency due to gene deletion and gene conversion in a patient with severe infections. Clin. Diagn. Lab. Immunol. 10, 195-201.

  467. Mok NS, Priori SG, Napolitano C, Chan NY, Chahine M, Baroudi G. (2003). A newly characterized SCN5A mutation underlying Brugada syndrome unmasked by hyperthermia. J. Cardiovasc. Electrophysiol. 14, 407-411.

  468. Park JH, Kim IJ, Kang H, Lee SH, Shin Y, Kim KH, Lim SB, Kang SB, Lee K, Kim S, Lee MS, Lee MK, Park JH, Moon SD, Park JG. (2003). Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders. Clin Genet 64:48-53.

  469. Jansson M, Marknell T, Tomic L, Larsson L, Wadelius C. (2003). Allelic variants in the MYOC/TIGR gene in patients with primary open-angle, exfoliative glaucoma and unaffected controls. Ophthalmic Genet 24:103-110.

  470. Dupre N, Verlaan DJ, Hand CK, Laurent SB, Turecki G, Davenport WJ, Acciarri N, Dichgans J, Ohkuma A, Siegel AM, Rouleau GA. (2003). Linkage to the CCM2 locus and genetic heterogeneity in familial cerebral cavernous malformation. Can J Neurol Sci 30:122-128.

  471. Gennaro E, Veggiotti P, Malacarne M, Madia F, Cecconi M, Cardinali S, Cassetti A, Cecconi I, Bertini E, Bianchi A, Gobbi G, Zara F. (2003). Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. Epileptic Disord 5:21-25.

  472. Girardet A, Cathala P, Claustres M. (2003). Rapid detection of the deltaF508 mutation in single cells using DHPLC: implications for preimplantation genetic diagnosis. J Assist Reprod Genet 20:153-156.

  473. Colosimo A, Guida V, Rigoli L, Di Bella C, De Luca A, Briuglia S, Stuppia L, Carmelo Salpietro D, Dallapiccola B. (2003). Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum Mutat 21:622-629.

  474. Tuffery-Giraud S, Saquet C, Chambert S, Claustres M. (2003). Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat 21:608-614.

  475. Mogensen J, Bahl A, Kubo T, Elanko N, Taylor R, McKenna WJ. (2003). Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy. J Med Genet 40(5):E59.

  476. Tartaglia M, Cotter PD, Zampino G, Gelb BD, Rauen KA. (2003). Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes. Clin. Genet. 63:423-426.

  477. Robertson SP, Twigg SR, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, Kenwrick SJ, Kim CA, Morava E, Newbury-Ecob R, Orstavik KH, Quarrell OW, Schwartz CE, Shears DJ, Suri M, Kendrick-Jones J, TE, Cross NC, Tefferi A. (2003). Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 101:3391-3397.

  478. Hung CC, Farooqi IS, Ong K, Luan J, Keogh JM, Pembrey M, Yeo GS, Dunger D, Wareham NJ, O'Rahilly S. (2003). Contribution of Variants in the Small Heterodimer Partner Gene to Birthweight, Adiposity, and Insulin Levels: Mutational Analysis and Association Studies in Multiple Populations. Diabetes 52:1288-1291.

  479. Sobrido MJ, Abu-Khalil A, Weintraub S, Johnson N, Quinn B, Cummings JL, Mesulam MM, Geschwind DH. (2003). Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neuorology 60:862-864.

  480. Claes L, Ceulemans B, Audenaert D, Smets K, Lofgren A, Del-Favero J, Ala-Mello S, Basel-Vanagaite L, Plecko B, Raskin S, Thiry P, Wolf NI, Van Broeckhoven C, De Jonghe P. (2003). De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum Mutat 21:615-621.

  481. Benit P, Beugnot R, Chretien D, Giurgea I, De Lonlay-Debeney P, Issartel JP, Corral-Debrinski M, Kerscher S, Rustin P, Rotig A, Munnich A. (2003). Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat 21:582-586.

  482. Hofer A, Hermans M, Kubassek N, Sitzer M, Funke H, Stogbauer F, Ivaskevicius V, Oldenburg J, Burtscher J, Knopp U, Schoch B, Wanke I, Wilkie AO; OPD-spectrum Disorders Clinical Collaborative Group. (2003). Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet 33:487-491.

  483. Pardanani A, Reeder T, Porrata LF, Li CY, Tazelaar HD, Baxter EJ, Witzig Hubner F, Deinsberger W, Meyer B, Boecher-Schwarz H, Poewe W, Raabe A, Steinmetz H, Auburger G. (2003). Elastin polymorphism haplotype and intracranial aneurysms are not associated in central Europe. Stroke 34:1207-1211.

  484. Pfendner EG, Nakano A, Pulkkinen L, Christiano AM, Uitto J. (2003). Prenatal diagnosis for Epidermolysis bullosa: a study of 144 consecutive pregnancies at risk. Prenat Diagn 23:447-456.

  485. Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, Wagner TMU, Oefner PJ. (2003). Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 63:3325-3333.

  486. LaBerge GS, Shelton RJ, Danielson PB. (2003). Forensic utility of mitochondrial DNA analysis based on denaturing high-performance liquid chromatography. Croat Med J 44:281-288.

  487. Su YN, Lee CN, Hung CC, Chen CA, Cheng WF, Tsao PN, Yu CL, Hsieh FJ. (2003) Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC. Hum Mutat. 2003 Oct;22(4):326-36.

  488. Danielson PB, Shelton RJ, LaBerge GS. (2003) Clinical applications of denaturing high-performance liquid chromatography-based genotyping. Croat Med J. 2003 Aug;44(4):447-54.

  489. Ye J, Ding J, Chen Y, Huang J, Yang J. (2003) Analysis of glucocorticoid receptor gene polymorphisms by denaturing high-performance liquid chromatography. Beijing Da Xue Xue Bao. 2003 Aug;35(4):394-8.

  490. Deng S, Wang Y, Ke Y, Xu G. (2003) Analysis of the mutations of BRCA1 in 9 familiar breast cancer patients. Beijing Da Xue Xue Bao. 2003 Aug;35(4):373-6.

  491. Meyer P, Voigtlaender T, Bartram CR, Klaes R. (2003) Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany. Hum Mutat. 2003 Sep;22(3):259.

  492. Bicocchi MP, Pasino M, Lanza T, Bottini F, Boeri E, Mori PG, Molinari AC, Rosano C, Acquila M. (2003) Analysis of 18 novel mutations in the factor VIII gene. Br J Haematol. 2003 Sep;122(5):810-7. 

  493. Wang YP, Zhang JN, Li JT, Zhou JN, Zhang XM, Zhu M. (2003) Mutation analysis on MSH2 and MLH1 genes in patients of colorectal cancer at early age. Zhonghua Yi Xue Za Zhi. 2003 Aug;83(15):1326-30.

  494. Mihalatos M, Apessos A, Triantafillidis JK, Kosmidis PA, Fountzilas G, Agnantis NJ, Yannoukakos D, Nasioulas G. (2003) Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort. Anticancer Res. 2003 May-Jun;23(3B):2691-5.

  495. Xu L, Pan-Hammarstrom Q, Forsti A, Hemminki K, Hammarstrom L, Labuda D, Gustafsson JA, Dahlman-Wright K. (2003) Human estrogen receptor beta 548 is not a common variant in three distinct populations. Endocrinology. 2003 Aug;144(8):3541-6.

  496. Sasaki G, Ogata T, Ishii T, Kosaki K, Sato S, Homma K, Takahashi T, Hasegawa T, Matsuo N. (2003). Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. J Clin Endocrinol Metab 88:3431-3436.

  497. Harold D, Peirce T, Moskvina V, Myers A, Jones S, Hollingworth P, Moore P, Lovestone S, Powell J, Foy C, Archer N, Walter S, Edmonson A, McIlroy S, Craig D, Passmore PA, Goate A, Hardy J, O'Donovan M, Williams J, Liddell M, Owen MJ, Jones L. (2003). Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum. Genet. 113, 258-267.

  498. Temam S, Trassard M, Leroux G, Bosq J, Luboinski B, Lenoir G, Benard J, Janot F. (2003). Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients. Br. J. Cancer 88, 1740-1745.

  499. Nakayama J, Hamano K, Noguchi E, Horiuchi Y, Iwasaki N, Ohta M, Nakahara S, Naoi T, Matsui A, Arinami T. (2003). Failure to find causal mutations in the GABA(A)-receptor gamma2 subunit (GABRG2) gene in Japanese febrile seizure patients. Neurosci Lett 343:117-120.

  500. Kim IJ, Park JH, Kang HC, Shin Y, Lim SB, Ku JL, Yang HK, Lee KU, Park JG. (2003). A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer. J Med Genet 40:E97.

  501. Washizuka S, Kakiuchi C, Mori K, Kunugi H, Tajima O, Akiyama T, Nanko S, Kato T. (2003). Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet 120B:72-78.

  502. Rindermann M, Grunig E, von Hippel A, Koehler R, Miltenberger-Miltenyi G, Mereles D, Arnold K, Pauciulo M, Nichols W, Olschewski H, Hoeper MM, Winkler J, Katus HA, Kubler W, Bartram CR, Janssen B. (2003). Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31. J. Am. Coll. Cardiol. 41, 2237-2244.

  503. Weigell-Weber M, Sarra GM, Kotzot D, Sandkuijl L, Messmer E, Hergersberg M. (2003). Genomewide homozygosity mapping and molecular analysis of a candidate gene located on 22q13 (fibulin-1) in a previously undescribed vitreoretinal dystrophy. Arch. Ophthalmol. 121, 1184-1188.

  504. Twells RC, Mein CA, Phillips MS, Hess JF, Veijola R, Gilbey M, Bright M, Metzker M, Lie BA, Kingsnorth A, Gregory E, Nakagawa Y, Snook H, Wang WY, Masters J, Johnson G, Eaves I, Howson JM, Clayton D, Cordell HJ, Nutland S, Rance H, Carr P, Todd JA. (2003). Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene. Genome Res. 13, 845-855.

  505. Lehavi O, Aizenstein O, Bercovich D, Pavzner D, Shomrat R, Orr-Urtreger A, Yaron Y. (2003) Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews. Genet Test. 2003 Summer;7(2):139-42.

  506. Fischer J, Schwab M, Eichelbaum M, Zanger UM. (2003) Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography. Genet Test. 2003 Summer;7(2):97-105.

  507. Raghunathan A, Palsson BO. (2003) Scalable method to determine mutations that occur during adaptive evolution of Escherichia coli. Biotechnol Lett. 2003 Mar;25(5):435-41.

  508. Furu L, Onuchic LF, Gharavi A, Hou X, Esquivel EL, Nagasawa Y, Bergmann C, Senderek J, Avner E, Zerres K, Germino GG, Guay-Woodford LM, Somlo S. (2003) Milder presentation of recessive polycystic kidney disease requires presence of amino Acid substitution mutations. J Am Soc Nephrol. 2003 Aug;14(8):2004-14.

  509. Melki R, Belmouden A, Brezin A, Garchon HJ. (2003) Myocilin analysis by DHPLC in French POAG patients: Increased prevalence of Q368X mutation. Hum Mutat. 2003 Aug;22(2):179.

  510. Melki R, Idhajji A, Driouiche S, Hassani M, Boukabboucha A, Akhayat O, Garchon H, Belmouden A. (2003) Mutational analysis of the Myocilin gene in patients with primary open-angle glaucoma in Morocco. Ophthalmic Genet. 2003 Sep;24(3):153-60.

  511. Porkka KP, Nupponen NN, Tammela TL, Vessella RL, Visakorpi T. (2003) Human pHyde is not a classical tumor suppressor gene in prostate cancer. Int J Cancer. 2003 Sep 20;106(5):729-35.

  512. Do B, Lossos IS, Thorstenson Y, Oefner PJ, Levy R. (2003) Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma. Leuk Lymphoma. 2003 Aug;44(8):1317-23.

  513. zur Stadt U, Eckert C, Rischewski J, Michael K, Golta S, Muller M, Schneppenheim R, Kabisch H. (2003) Identification and characterisation of clonal incomplete T-cell-receptor Vdelta2-Ddelta3/Ddelta2-Ddelta3 rearrangements by denaturing high-performance liquid chromatography and subsequent fragment collection: implications for minimal residual disease monitoring in childhood acute lymphoblastic leukemia. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 25;792(2):287-98.

  514. Su ZG, Zhang SZ, Zhang L, Tong Y, Xiao CY, Hou YP, Liao LC. (2003) A novel polymorphism A(+884)-->G in the hepatic lipase gene and its association with coronary artery disease. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Jul;35(7):606-10.

  515. Rossetti S, Torra R, Coto E, Consugar M, Kubly V, Malaga S, Navarro M, El-Youssef M, Torres VE, Harris PC. (2003) A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int. 2003 Aug;64(2):391-403.

  516. Flanagan J, Healey S, Young J, Whitehall V, Chenevix-Trench G. (2003) Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancer. Int J Cancer. 2003 Sep 10;106(4):505-9.

  517. Wei SC, Yu CY, Tsai-Wu JJ, Su YN, Sheu JC, Wu CH, Wang CY, Wong JM. (2003). Low mutation rate of hMSH2 and hMLH1 in Taiwanese hereditary non-polyposis colorectal cancer. Clin Genet 64:243-251.

  518. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34, 383-394.

  519. Hyland VJ, Robertson SP, Flanagan S, Savarirayan R, Roscioli T, Masel J, Hayes M, Glass IA. (2003) Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia. Am J Med Genet. 2003 Jul 15;120A(2):157-68.

  520. Hendy GN, Minutti C, Canaff L, Pidasheva S, Yang B, Nouhi Z, Zimmerman D, Wei C, Cole DE. (2003) Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene. J Clin Endocrinol Metab. 2003 Aug;88(8):3674-81.

  521. Pfendner EG, Nakano A, Pulkkinen L, Christiano AM, Uitto J. (2003) Prenatal diagnosis for epidermolysis bullosa: a study of 144 consecutive pregnancies at risk. Prenat Diagn. 2003 Jun;23(6):447-56.

  522. Etokebe GE, Opsahl M, Tveter AK, Lie BA, Thorsby E, Vartdal F, Spurkland A. (2003) Physical separation of HLA-A alleles by denaturing high-performance liquid chromatography. Tissue Antigens. 2003 Jun;61(6):443-50.

  523. Mitui M, Campbell C, Coutinho G, Sun X, Lai CH, Thorstenson Y, Castellvi-Bel S, Fernandez L, Monros E, Carvalho BT, Porras O, Fontan G, Gatti RA. (2003) Independent mutational events are rare in the ATM gene: haplotype prescreening enhances mutation detection rate. Hum Mutat. 2003 Jul;22(1):43-50.

  524. Cremonesi L, Stenirri S, Fermo I, Paroni R, Ferrari M, Cazzola M, Arosio P. (2003) Denaturing HPLC analysis of DNA deletions and insertions. Hum Mutat. 2003 Jul;22(1):98-102. 

  525. Schmidt S, Postel EA, Agarwal A, Allen IC Jr, Walters SN, De la Paz MA, Scott WK, Haines JL, Pericak-Vance MA, Gilbert JR. (2003) Detailed analysis of allelic variation in the ABCA4 gene in age-related maculopathy. Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2868-75.

  526. Steensma DP, Higgs DR, Fisher CA, Gibbons RJ. (2003). Acquired somatic ATRX mutations in myelodysplastic syndrome associated with {alpha} thalassemia (ATMDS) convey a more severe hematological phenotype than germline ATRX mutations. Blood. 2003 Oct 30 [Epub ahead of print]

  527. Varon R, Schoch C, Reis A, Hiddemann W, Sperling K, Schnittger S. (2003). Mutation Analysis of the Nijmegen Breakage Syndrome Gene (NBS1) in Nineteen Patients with Acute Myeloid Leukemia with Complex Karyotypes. Leuk. Lymphoma 44, 1931-1934.

  528. Bianchini M, Ottaviani E, Grafone T, Giannini B, Soverini S, Terragna C, Amabile M, Piccaluga PP, Malagola M, Rondoni M, Bosi C, Baccarani M, Martinelli G. (2003). Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC. Clin Chem. 2003 Oct;49(10):1642-50.

  529. Kabesch M, Tzotcheva I, Carr D, Hofler C, Weiland SK, Fritzsch C, Von Mutius E, Martinez FD. (2003). A complete screening of the IL4 gene: Novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol. 2003 Nov;112(5):893-8.

  530. Cremonesi L, Foglieni B, Fermo I, Cozzi A, Paroni R, Ruggeri G, Belloli S, Levi S, Fargion S, Ferrari M, Arosio P. (2003). Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. Haematologica. 2003 Oct;88(10):1110-6.

  531. Koenekoop RK, Loyer M, Hand CK, Al Mahdi H, Dembinska O, Beneish R, Racine J, Rouleau GA. (2003). Novel RPGR mutations with distinct retinitis pigmentosa phenotypes in French-Canadian families. Am J Ophthalmol. 2003 Oct;136(4):678-87.

  532. Isidro G, Matos S, Goncalves V, Cavaleiro C, Antunes O, Marinho C, Soares J, Boavida MG. (2003). Novel MLH1 mutations and a novel MSH2 polymorphism identified by SSCP and DHPLC in Portuguese HNPCC families. Hum Mutat. 2003 Nov;22(5):419-20.

  533. Spinarova L, Toman J, Hude P, Vohanka S, Vytopil M, Lukas Z, Novak M, Vitovec J. (2003). [Disorders of laminins in diseases of myocardial and skeletal muscles] Vnitr Lek. 2003 Aug;49(8):637-41.

  534. Semple JI, Ribas G, Hillyard G, Brown SE, Sanderson CM, Campbell RD. (2003). A novel gene encoding a coiled-coil mitochondrial protein located at the telomeric end of the human MHC Class III region. Gene. 2003 Sep 18;314:41-54.

  535. Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum SL, Olsen JH, Anton-Culver H, Boice JD, Rosenstein BS, Borresen-Dale AL, Gatti RA, Concannon P, Haile RW; WECARE Study Collaborative Group. (2003). ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Br J Cancer. 2003 Oct 20;89(8):1513-6.

  536. Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius E, Escary JL, Berthon P, Cussenot O. (2003). Association study of polymorphisms in the human estrogen receptor alpha geLatil Ane and prostate cancer risk. Eur Urol. 2003 Oct;44(4):487-90.

  537. Wang XD, Fu Y, Jiang HJ, Morisaki H, Morisaki T. (2003). The application of denaturing high performance liquid chromatography in detection of novel polymorphisms in PAI-1gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Oct;20(5):404-8.

  538. Gurtler N, Kim Y, Mhatre A, Muller R, Probst R, Lalwani AK. (2003). GJB2 mutations in the Swiss hearing impaired. Ear Hear. 2003 Oct;24(5):440-7.

  top of page
 
mail to webmaster| last updated 10/11/2003